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Presentación 
 
La poli-ploidización es un proceso natural mediante el cual diversos tipos celulares aumentan 
la ploidía mediante la replicación del ADN en ausencia de segregación cromosómica. Este 
proceso forma parte del desarrollo normal de varios tejidos en plantas y animales, aunque las 
alteraciones en ploidía son también un hecho característico de la transformación maligna en 
cáncer. Los megacariocitos normalmente sufren varias rondas de poli-ploidización para 
convertirse en células gigantes capaces de generar plaquetas, aunque la base molecular de este 
processo se desconoce en detalle. En el presente estudio hemos analizado la relevancia de 
varios reguladores del ciclo celular en el proceso de megacariopoiesis y en los eventos de 
poli-ploidización que tienen lugar durante la maduración de megacarioticos. Mastl es una 
quinasa que inhibe fosfatasas durante mitosis y cuyo gen se encontró inicialmente mutado en 
pacientes con trombocitopenia. Mediante la generación de ratones knockin que llevan la 
mutación correspondiente, hemos encontrado que Mastl se requiere para atenuar la actividad 
de los complejos PP2A-B55 y modular la señalización por MAPK durante la maduración de 
estas células. Para profundizar en el control de la maduración de megacariocitos y la 
formación de plaquetas, hemos analizado el efecto de la eliminación genética en estas células 
de varios reguladores del ciclo celular que participan en la entrada, progresión y salida de 
mitosis. El complejo APC/C (Anaphase-promoting complex)-Cdc20 es necesario para la 
salida de endomitosis ya que los megacariocitos deficientes en Cdc20 se detienen 
permanentemente en mitosis dando lugar a trombocitopenia severa en los animales. El APC/C 
es sin embargo prescindible para la producción de plaquetas cuando se activa por el cofactor 
Cdh1, una proteína requerida para endoreplicación en otros sistemas. Sorprendentemente, la 
eliminación de Cdk1, una quinasa esencial para la mitosis en todas las células analizadas, no 
produce trombocitopenia. Esto se debe a la capacidad de los megacariocitos deficientes en 
Cdk1 de endoreplicar como un ciclo celular alternativo. Los megacariocitos deficientes en 
Cdk1 generan plaquetas de manera normal cuando se estimulan con TPO. La eliminación 
concomitante de la quinasa Cdk2 en megacariocitos deficientes en Cdk1 resulta en eventos de 
re-replicación acompañados por estrés replicativo. Inesperadamente, estos megacariocitos son 
capaces de madurar apropiadamente y formar plaquetas utilizando re-replicación en lugar de 
endomitosis o endoreplication. La ablación genética de Cdk1 o Cdk1 y Cdk2 es capaz de 
rescatar los defectos en el número de plaquetas observados en los ratones deficientes en 
Cdc20; indicando que la endoreplicación y la re-replicación es capaz de reemplazar 
funcionalmente a la endomitosis in vivo. En conjunto, este análisis sugiere que la poli-
ploidización funcional puede ser obtenida a través de múltiples endociclos alternativos in 
vivo. Estos datos no sólo arrojan luz sobre cuestiones básicas de la biología celular, sino que 
también pueden tener interés en posibles nuevos enfoques terapéuticos contra los ciclos 
celulares mitóticas en células cancerígenas. 
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Abstract 
 
Polyploidization is a natural process by which specific cell types increase ploidy by 
replicating DNA in the absence of chromosome segregation. This process is part of the 
normal development of specific tissues in plants and animals, and altered ploidy is also 
observed as an accompanying feature of malignant transformation in cancer. Megakaryocytes 
normally poplyploidize to become mature giant cells able to generate platelets However, the 
molecular basis of polyploidization in these cells is mostly unknown. In the present study we 
have analyzed the relevance of well-established cell cycle regulators in the process of 
megakaryopoiesis and more specific in the particular polyploidization events that take place 
during the development and maturation of these platelet-producing cells. Mastl, a kinase 
regulating phosphatase complexes during mitosis, was initially found in humans as a gene 
mutated in human thrombocytopenia. By generating knockin mice carrying the corresponding 
mutation, we describe here that this protein is required to attenuate PP2A-B55 activity and to 
modulate MAPK signaling and proplatelet formation during the development of 
megakaryocytes. To further understand the control of megakaryocyte maturation and platelet 
formation by cell cycle regulators, we specifically ablated several cell cycle regulators 
involved in mitotic entry, progression and exit, using a megakaryocyte-specific Cre model in 
the mouse. Using these models, we demonstrate here that unperturbed megakaryocytes 
undergo endomitosis in vivo, a process in which cells replicate the DNA but chromosomes are 
not segregated due to incomplete mitosis. The Anaphase-promoting Complex (APC/C)-
Cdc20 is necessary for endomitotic exit since Cdc20-null megakaryocytes were arrested in 
mitosis leading to severe thrombocytopenia. However, APC/C is dispensable for platelet 
production when activated by the Cdc20-related cofactor Cdh1, a protein required for 
endoreplication in other systems. Strikingly, ablation of Cdk1, a cell cycle kinase essential for 
mitosis in all cells analyzed, does not lead to thrombocytopenia development. The reason 
behind this observation is the ability of Cdk1-null megakaryocytes to endoreplicate as an 
alternative cell cycle. Mature megakaryocytes arising from endoreplicative cell cycles were 
able to shed platelets upon TPO stimulation in vitro, even though this procedure was carried 
out less efficiently. Further ablation of Cdk2 kinase in Cdk1-null megakaryocytes resulted in 
re-replication events. Unexpectedly, megakaryocytes were able to undergo functional 
polyploidization using re-replication and Cdk1; Cdk2 double mutant mice displayed normal 
differentiation of megakaryocytes in the absence of thrombocytopenia. Interestingly, genetic 
ablation of Cdk1 and Cdk2 rescued platelet defects in Cdc20-deficient mice indicating that 
endoreplication and re-replication can functional replace endomitosis in vivo. Altogether, this 
analysis suggests the presence of multiple endocycles that can be alternatively used during 
functional polyploidization. These data not only shed light on basic cellular biology questions 
but may also be of relevance for possible therapeutic approaches against cancer mitotic cell 
cycles. 
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1.1. Genome ploidy in eukaryotes 
1.1.1. Polyploidy  
Multicellular organisms have a wide variety of cells in order to accomplish their diverse and 
complex necessities. One interest aspect of this cellular diversity is that many cells in diploid 
organisms are polyploid. Polyploid cells that contain multiple sets of chromosomes were first 
observed in plants in 1910 (Strassburger 1910) since then, polyploidy has been studied in a 
variety of organisms from bacteria to higher eukaryotes as well as in humans. Polyploidy can 
take place as part of a well-coordinated developmental program but also as a response to 
certain stresses, either physiological or not, which in turn can lead to pathological conditions 
and disease (Figure 1.1). For this reason is important not only to understand the requirements 
for polyploidy in several tissues in the mammalian organisms but also the molecular 
mechanisms that underlay this process and how they can be modulated.  
Polyploidy mainly arises from cell cycles known as endocycles which are divergent 
from the typical mitotic process, although there are also other mechanisms that can contribute 
to polyploidy such as cellular fusion (Edgar et al., 2014). A conventional cell cycle can be 
divided in two periods: Mitosis and interphase (Figure 1.2). The name “mitosis” comes from 
the Greek word “mitos” meaning thread to describe the threadlike chromosomes that appear 
just before cell division and then are 
separated longitudinally into two new cells 
resulting from the original cell. The 
interphase which actually prepares cells for 
division during mitosis can be subdivided 
further into distinct parts: the S phase (where 
S is for DNA “Synthesis”) during which the 
cells will replicate its entire genomic 
material, and two Gap phases, G1 and G2, in 
which cells prepare to proceed to S phase or 
to mitosis respectively (Figure 1.2). 
1.1.2. Endocycles 
Endocycling refers to unconventional cell 
cycling with variations from the canonical 
G1-S-G2-M cell cycle during which the cell 
executes S phase replicating its genome, 
either entirely or partially, but without 
segregation of the replicated genome into 
Figure 1.1. Polyploidy during physiological and 
pathological processes. Polyploid cells are 
generated during physiological processes, such as 
embryogenesis (placenta: trophoblast giant cells), 
postnatal development (heart: cardiomyocytes or 
liver: hepatocytes), and terminal differentiation (bone 
marrow megakaryocytes); and also during 
pathological processes, such as hypertension 
(vascular smooth muscle cells), virus infection 
(human papilloma virus), and tumorigenesis 
(esophageal and colon cancers). 
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two or more daughter cells. Endocycles use much of the same cell machinery that regulates 
the transition from G1 to S phase as mitotic cell cycles and mainly differ from mitotic cells in 
their capability to segregate chromosomes and divide (Edgar et al. 2014). Some examples of 
polyploid cells that result from endocycling in mammals are the trophoblast giant cells 
(TGCs) in the placenta, hepatocytes in the liver, and megakaryocytes in the bone marrow. 
Each of these cell types undergoes a different kind of endocycling such as endoreplication, 
endomitosis or acytokinetic mitosis. Although many variations of the nomenclature exit, we 
will define the different processes as shown in Figure 1.2.  
 
 
Figure 1.2. Endocycles versus mitotic cell cycles. Mitotic cell cycles are characterized by a gap phase 
(G1) prior to S-phase (S) where DNA synthesis occurs and then follows another gap phase (G2) prior to 
mitosis (M) during which the cell is divided in two daughter cells. Endocycling refers to cell cycles that result 
in polyploid cells and consists of variances of the conventional mitotic cell cycle. Endoreplication consists 
of G and S phases without entry into mitosis and trophoblast giant cells in the placenta arise from 
endoreplicative cell cycles resulting in a single polyploid nucleus. Endomitosis or abortive mitosis is the 
cell cycling during which cells do enter in mitosis but skip the late evens of anaphase, telophase, and 
cytokinesis. In late anaphase, the nuclear envelope reforms around the segregated chromosomes, leading 
to the formation of a single polylobulated nucleus. Megakaryocytes use endomitosis for polyploidization Re-
replication results from aberrant regulation in which DNA synthesis is initiated multiple times at individual 
origins of replication within a single S phase. This results in an indistinct DNA content as depicted by black 
lines in this hypothetical FACS profile (Y-axis is cell number and X-axis is DNA content). Green represents 
the diploid mitotic cell cycle profile, with 2C and 4C peaks. Red represents endoreplication cycles that result 
in distinct populations of cells with more than a 4C DNA content. Although re-replication is not properly an 
endocycle, we will include it here for simplicity. During Acytokinetic mitosis, cells do enter mitosis and 
segregate chromosomes but fail to perform cytokinesis resulting in binucleated cells. Hepatocytes in liver 
and cardiomyocytes in heart during development polyploidize through acytokinetic mitosis. 
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Endoreplication refers to an endocycle in which successive rounds of S-phase followed 
by G-phase occur without intervening mitosis, resulting in cells with a single polyploid 
nucleus (Figure 1.2). This process of endoreplication has been extensively investigated in flies 
(D. melanogaster) and TGCs (Edgar and Orr-Weaver, 2001; Lee et al. 2009; Edgar et al., 
2014; Sher et al. 2013). In contrast to Drosophila endocycling in which heterochromatin and 
specific euchromatin regions are underreplicated and reduced in copy number, in TGCs the 
genome is uniformly and integrally duplicated by clearly delineated genome doublings. This 
is an important distinction from the aberrant process of re-replication which is characterized 
by uncontrolled, continuous reinitiation of DNA synthesis within a given S phase, leading in 
increases in DNA content without clearly recognizable genome doublings (Arias & Walter 
2007). Re-replication can lead as well to polyploidy even though it does not exist in nature 
and can result only from perturbations to the molecular mechanisms that control the ‘‘once 
and only once’’ firing of replication origins during a normal diploid S phase, and is thought to 
be a source of genome instability that contributes to cancer. 
Another major form of endocycling is the acytokinetic mitosis during which cells that 
have entered and finished mitosis do not complete cytokinesis, giving rise to binucleated 
cells. This process occurs during liver and heart development to produce multinucleated 
hepatocytes (mainly binucleated) or cardiomyocytes. In contrast to cardiomyocytes, which 
generate a contractile cytokinetic ring that is not functional for separating daughter cells 
(Engel et al. 2006), hepatocytes never form an actinomyosin ring during the binucleation 
process (Margall-Ducos et al. 2007; Duncan 2013). 
Endomitosis (also known as abortive mitosis) is another type of endocycle that has been 
described to take place in megakaryocytes, the cell precursors of platelets. Normal mitotic 
cells undergo nuclear envelope breakdown in prometaphase (P/M), alignment of 
chromosomes to the equator of the cells in metaphase (M) and chromatide segregation in 
anaphase (A). Then, nuclear envelope reformation occurs in telophase (T) and the cytoplasm 
is splitted into the two new nuclei to form two completely separated daughter cells during 
cytokinesis (Figure 1.3). To reach polyploidy through endomitosis, cells enter mitosis but skip 
the late evens of anaphase, telophase, and cytokinesis (Figure 1.3). In anaphase, the nuclear 
envelope reforms around partially segregated chromosomes, leading to the formation of a 
single polylobulated nucleus with a genome content up to 64-128 sets of chromosomes (64-
128C) in humans, where each lobe presumably contains a diploid genome (Ravid et al. 2002). 
Eventually after several rounds of polyploidization megakaryocyte suffer a process of 
maturation during which cells are withdrawn from the cell cycle in a senescent-like state 
(Besancenot et al. 2010). Megakaryocyte maturation comes to completion with the release of 
platelets into the bloodstream.  
Introduction 
 
24 
 
 
Figure 1.3. Mitotic and endomitotic cell cycles. Mitotic cells undergo nuclear envelope breakdown in 
prometaphase (P/M), alignment of chromosomes to the equator of the cells in metaphase (M) and 
chromatid segregation in anaphase (A). These cells then proceed to the last part of mitosis (telophase, T) 
during which nuclear envelope reformation and furrow ingression occurs. The cytoplasm is then divided into 
two new nuclei to form two completely separated daughter cells during cytokinesis. In the endomitotic cell 
cycle, cells enter mitosis but skip the late evens of anaphase, telophase, and cytokinesis. In anaphase, the 
nuclear envelope reforms around the segregated chromosomes, leading to the formation of a single 
polylobulated nucleus with a genome content up to 64C in the mouse or 128C in humans, where each lobe 
presumably contains a diploid genome. Eventually after several rounds of polyploidization megakaryocyte 
suffer a process of maturation during which cells are withdrawn from the cell cycle in a senescent-like state. 
Upon maturation, megakaryocytes form pro-platelets that are ablt to release platelets in the blood stream. 
The currently favored model of platelet production recognizes that differentiated 
megakaryocytes extend long cytoplasmic processes, designated proplatelets. Proplatelets 
function as the assembly lines of platelet production and comprise platelet-sized swellings in 
tandem arrays that are linked by thin cytoplasmic bridges (Figure 1.3). 
1.2. Molecular basis of the cell cycle 
To investigate the molecular basis that determines endocycling we need first to review the 
molecular basis that underlies the normal mitotic cell cycle since endocycles use much of the 
same cell cycle machinery.  
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1.2.1. The mitotic cell cycle 
The first requirement for cell cycle progression from G1 to S phase relies on the expression of 
cell cycle genes as a result of numerous mitogenic signals. These signals trigger the 
inactivation of the retinoblastoma protein (pRb) through phosphorylation by cyclin-dependent 
kinases (Cdks). pRb inactivation results in the activation of several transcription factors and in 
a massive transcription during G1 of genes required for the subsequent cell cycle phases 
(Malumbres & Barbacid, 2001). The Cdk-cyclin responsible for the first inactivating wave of 
pRb is the Cdk4/6-cyclin D complex. Partial inactivation of pRb and the other pocket family 
proteins p107 and p130 allows the activation of several transcription factors such as the E2F 
family responsible for the expression of genes required for the entry into the S-phase. One 
important target of E2F is cyclin E which can bind and activate Cdk1 and Cdk2. Cdk2-Cyclin 
E is thought to participate in pRb hyperphosphorylation and its complete inactivation and the 
subsequent entry into S-phase (Malumbres & Barbacid 2001), although this activity is 
dispensable in normal tissues (Ortega et al. 2003). 
Once Cdk activity raises this allows the firing of the replication origins that have been 
“licensed” during the G1 phase. Licensing refers to the loading of the pre-replication 
complexes (PreRCs) onto the replication origins. Origin firing determines S-phase entry. 
Cdk1/2-cyclin A is then responsible to ensure the ‘‘once and only once’’ firing of replication 
origins by preventing the origin relicensing during late S-phase and G2 (Hook et al. 2007). 
During G2, the cell ensures that the genome doubling has been completed properly by the 
activation of checkpoints and prepares the cell for entry into mitosis.  
An important event during G2 is centrosome organization during which the duplicated 
centrosomes move towards different poles of the cells. In addition to some Cdk family 
members, other kinases are specifically dedicated to drive centrosome duplication and 
maturation and to increase their ability to nucleate microtubules during these stages, including 
Aurora and Polo-like kinases or the never in mitosis a (NIMA)-related kinases (Neks; 
Malumbres, 2011). The critical molecular activity required for entry into mitosis is Cdk1 
kinase. During the G2/M transition, a large number of proteins are phosphorylated in a Cdk1-
dependent manner resulting in cytoplasmic changes, Golgi disassembly, nuclear envelope 
breakdown, and condensation of chromosomes. Some other kinase activities, mainly from 
Polo or Aurora families, participate in mitotic entry either by activating specific phosphatases 
such as the Cdc25c which relieves the phosphorylation-dependent Cdk1inhibition (Plk1), or 
by helping in the establishment of the proper chromosome structures and the mitotic spindle 
(Lens et al. 2010). In addition, a new kinase involved in the inactivation of phosphatases, 
known as Mastl, participates by favoring the balance between Cdk1-dependent 
phosphorylation and dephosphorylation by general phosphatases such as protein phosphatase 
PP2A (Malumbres 2011; Glover 2012). A particular group of kinases, represented by Bub1, 
BubR1 kinases and Mps1 (also known as TTK), are critical components of the spindle 
assembly checkpoint (SAC or mitotic checkpoint), a signaling pathway that monitors bipolar 
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attachment of chromosomes to the mitotic spindle (Nezi & Musacchio, 2009). This 
checkpoint ensures proper segregation of chromosomes to daughter cells. Finally, Aurora B 
and Plk1 as well as the GTPase (Guanine nucleotide triphosphatase) RhoA are involved in 
cytokinesis (Figure 1.4) (Malumbres 2011; Su et al. 2011). 
Another important aspect of Cdk activity control is the ubiquitin-mediated proteolysis 
of key regulators such as cyclins and Cdk inhibitors. Two ubiquitin ligases, the SCF complex 
(Skip1-Cul1-F-box protein) and the APC/C (anaphase promoting complex/cyclosome), have a 
central role in cell cycle regulation. The SCF complex and the APC/C are both E3 ubiquitin 
ligases with similar structures (Nakayama & Nakayama, 2006; Skaar & Pagano 2009). The 
APC/C is active in mitosis and G1 while SCF exert it role mostly in interphase. Each is 
constituted of common subunits and a variable substrate recognition subunit that function as 
activator. Two activators of the APC/C, Cdc20 (cell division cycle 20) and Cdh1; and three F-
box proteins in the SCF complex, Skip2 (S-phase kinase-associated protein 2), Fbw7 (F-box 
and WD-40 domain protein 7) and β-TrCP (β-transducin repeat-containing protein), are the 
most important in cell-cycle regulation (Nakayama and Nakayama, 2006; Skaar and Pagano 
2009). 
 
Figure 1.4 An overview of the mammalian cell cycle and its regulation by kinases. In response to 
mitogenic signaling, cells enter into the cell cycle through the Cdk4/6-cyclin D-dependent inactivation of 
pRb. Entry into S-phase may also depend on Cdk2-cyclin E complexes. During the S phase, the genome 
(blue) is duplicated. In G2, kinases such as Aurora A or Plk1 are important for centrosome separation and 
movement towards different poles of the cells. During the G2/M transition Cdk1 is activated by cyclin B and 
phosphorylates a variety of substrates involved in Golgi disassembly, nuclear envelop breakdown, and 
condensation of chromosomes. During mitotic exit, the cytoplasm is divided into two daughter cells through 
cytokinesis. Microtubules are represented as red lines. Adapted from Malumbres, 2011.  
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Cdc20 is the crucial effector of the spindle assembly checkpoint and targets securin and 
mitotic cyclins for destruction, thereby promoting sister-chromatid separation and mitotic exit 
(Figure 1.5) (Peters, 2006; Manchado et al. 2010). Cdh1, on the other hand, facilitates exit 
from late mitosis and maintains G1 phase mediating the degradation of mitotic cyclins, non-
Cdk mitotic kinases such as Aurora and Plk1 and some regulators of the formation of pre-
replicative complexes (Figure 1.5). SCF-Skp2 targets inhibitors of the cell cycle such as 
p27Kip1, p21Cip1 and p57Kip2 for degradation and thereby promotes cell cycle progression. 
Fbw7 induces the degradation of positive regulators of the cell cycle, such as Myc, Jun, cyclin 
E and Notch. β-TrCP is a versatile F-box protein that recognizes several cell cycle regulators 
such as Emi1/2, Wee1A and Cdc25A/B (Nakayama & Nakayama 2006). 
 
 
Figure 1.5. Function of APC/C in the cell cycle. During the early stages of mitosis, APC/C–Cdc20 
ubiquitinates several substrates such as Nek2A, cyclin A and p21Cip1, promoting their degradation. Yet, in 
response to unattached kinetochores, the SAC is active and the APC/C is inhibited by sequestering of 
Cdc20 or non-functional APC/C–Cdc20 complexes also containing Mad2, Mad3 and BubR1. Under these 
conditions, securin and cyclin B–Cdk1 function as inhibitors of separase. Once all chromosomes are bi-
orientated on a metaphase plate, the SAC is extinguished, resulting in APC/C–Cdc20 activation. APC/C–
Cdc20 targets cyclin B1 and securin for degradation allowing separase activity, which cleaves the 
centromere cohesin complex leading to anaphase onset. The newly formed APC/C–Cdh1 complexes drive 
mitotic exit by targeting for destruction Plk1, Aurora A or Tpx2 among other substrates as well as Cdc20 
itself. During G1 phase, APC/C–Cdh1 maintains low levels of Cdk activity by targeting A- and B-type cyclins 
and several regulators of DNA replication such as Geminin or Cdc6. Finally, the APC catalyses the auto-
ubiquitination of its own E2 ubiquitin-conjugating enzyme UBE2C/UbcH10, leading to the stabilization of 
cyclin A, activation of Cdks and APC/C–Cdh1 inactivation. Source: (Manchado, et al. 2010). 
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1.2.2. Endoreplication 
To convert the mitotic cell cycle into an endoreplicative one, the cell cycle must show two 
essential features. First, the processes of mitosis must be bypassed without blocking DNA 
replication and second the Cdk activity required for DNA replication has to be periodically 
inactivated to enable the transition into a G phase. The first requirement for bypassing mitosis 
is accomplished by inhibiting Cdk1 which is the Cdk that drives G2-to-M phase progression, 
while allowing unperturbed the S-phase Cdk activity that drives G1-to-S progression (Edgar 
and Orr-Weaver 2001; Lee et al. 2009; Edgar et al. 2014).  
Several cell types can be experimentally forced into endoreplication by suppressing 
Cdk1 activity, which suggests that Cdk1 downregulation is sufficient to trigger 
endoreplication (Laronne & Rotkopf 2003). The second requirement for endoreplication 
which is accomplished by the SCF and the APC/C-Cdh1 ubiquitin ligases, has been clearly 
demonstrated by experiments in D. melanogaster showing that constitutive expression of 
Cyclin E, an S-phase Cdk activator, can block endocycling (Weiss et al. 1998). Also recently 
in murine TGCs has been demonstrated that APC/C activity oscillations take place during the 
endoreplicative cell cycles (Sakaue-Sawano et al. 2013). The underlying reason for this seems 
to be that the assembly of pre-replication complexes at origins of replication is inhibited by 
high levels of Cdk activity. Like mitotic cells, endocycling cells require a G1-like gap phase 
with low Cdk activity during which they can assemble PreRCs. Thus in this model that 
describes the progression of the endoreplicative cell cycles, G phases are characterized by low 
S-phase Cdk and Geminin activity and high APC/C-Cdh1 which allows PreRC formation. S 
phases have opposite characteristics: high S-phase Cdk and Geminin activity, which allows 
DNA replication but prevents PreRC formation.  
During the switch from a mitotic cell cycle to endoreplication, Cdk1 inactivation is 
thought to occur through the action of APC/C-Cdh1 and the Cdk inhibitor p57Kip2 (Ullah et 
al. 2008; Edgar et al. 2014). APC/C-Cdh1 activity is involved in mitotic cyclin destruction 
therefore mediating Cdk1 inhibition. Cdh1 is essential for endoreplication both in flies 
(Sigrist & Lehner 1997) and mice (Garcia-Higuera et al. 2008). Cdh1 ablation in mouse 
embryos leads to embryonic lethality due to placental defects. Cdh1 null placentas present 
aberrant TGCs with small nuclei confirming the requirement for Cdh1 in endoreplicative cell 
cycles. Interestingly, overexpression of Cdh1 in U2OS cells is sufficient to induce 
endoreplication (Sorensen et al. 2000). On the other hand TGCs have been detected in 
p57Kip2 knockout mice, suggesting that p57Kip2 is not essential for endocycle entry, or at 
least has redundant functions (P. Zhang et al. 1998). Severe placental abnormalities occur in 
p57Kip2-deficient mice, but so far it is unclear whether these are due to a compromised 
mitotic-to-endocycle transition or to a more general failure of cell cycle exit in progenitor 
cells. 
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1.2.3. Re-replication 
What enables endocycling cells to replicate their DNA many times within a single interphase 
is not entirely clear yet, but work in diverse mitotic systems does suggest what sort of 
mechanisms to expect. In eukaryotic cells, pre-RCs which consist at least of four factors, 
ORC, Cdc6, Cdt1 and MCM2-7, are assembled on chromatin in the G1 phase, rendering 
origins of DNA replication competent to initiate DNA synthesis (Arias & Walter 2007). 
When DNA replication commences in S phase, pre-RCs are disassembled, and multiple 
initiations from the same origin do not occur because new rounds of pre-RC assembly are 
inhibited. In most experimental organisms, multiple mechanisms that prevent pre-RC 
assembly have now been identified, and re-replication within the same cell cycle can be 
induced through defined perturbations of these mechanisms. In mammals, the main 
mechanisms to avoid re-replication are the Cdt1 proteolytic destruction, the sequestration of 
Cdt1 by Geminin and the Cdk1-mediated inhibition of ORC loading (Arias & Walter 2007; 
Hook et al. 2007) (Figure 1.6).  
Cdt1 is ubiquitinated in a PCNA-dependent manner by the E3 ubiquitin ligase cullin 
based complex Cul4-Ddb1Cdt2 during S-phase while during S and G2 phases is dependent on 
the SCFSkip2 ubiquitin ligase (Li & Blow 2004). Although all these mechanisms show 
redundant and overlaping properties there are many evidences showing that the overall Cdk 
activity is the one that controls many of those mechanisms and hence the cell ensures a proper 
replication of its genome (Li & Blow 2004). 
 
 
 
 
Figure 1.6. Mechanisms to prevent re-
replication in mammalian cells. In the center is 
the pre-RC which is a pre-requisite for replication 
initiation. The pathways highlighted with black 
lines are known to inhibit pre-RC formation and by 
doing so have been demonstrated to prevent re-
replication. The pathways denoted with dashed 
lines also inhibit pre-RC formation but have not 
yet been shown to prevent re-replication. The red 
lightening bolt denotes pathways activated by 
DNA damage. The boxed section shows Emi1 
which has been shown to prevent rereplication by 
stabilizing geminin and cyclin A.  Source: (Hook et 
al. 2007) 
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1.2.4. Endomitosis 
Since the first description of megakaryocytes as the origin of blood platelets in 1906 by James 
H. Wright, only during the last years the molecular basis for endomitosis has been described 
(Geddis & Kaushansky 2006; Lordier et al. 2008; Gao et al. 2012). Endomitotic cycles as 
mentioned above are characterized by entry into mitosis, nuclear breakdown and formation of 
complex mitotic spindles with multiple asters. At the end of each endomitosis, however, 
megakaryocytes abort anaphase, reverse or fail to initiate cytokinesis, and gather all the 
chromosomes in a single nucleus (Ravid et al. 2002; Machlus & Italiano 2013). While key 
cytoskeletal and regulatory components, including RhoA, Aurora B, and the chromosome 
passenger complex (CPC), localize correctly in the spindle midzone in early anaphase of the 
first endomitotic cycle it has been showed that a cleavage furrow slowly begins to ingress and 
later regresses (Geddis & Kaushansky 2006). In subsequent cycles, furrow ingression is 
barely perceptible, and the contractile ring lacks nonmuscle myosin IIA. These observations 
highlight differences between the first and subsequent endomitotic cycles, with both types 
showing defective cleavage furrow ingression, a process that requires RhoA-mediated 
actomyosin contraction. Till recently, single components of the spindle midzone such as 
Aurora B (see Section 1.4.1) and cleavage furrow such RhoA were not conclusive offering 
satisfying reasons for abortive cytokinesis. The first complete and satisfying explanation for 
the abortive mitosis in megakaryocytes was given in 2012 by Gao et. al. They showed that 
RhoA localizes correctly in the spindle midzone and latter in furrow formation but fails to be 
activated, attributing this failure to reduced levels of two RhoA-activating guanine exchange 
factors (GEFs), GEF-H1 and Ect2 (Gao et al. 2012).  
1.3. Significance of polyploidization in mammalian cells 
To define the physiological role of polyploidization it is crucial to determine the 
consequences of increasing or reducing polyploidization in vivo. Recently, multiple mouse 
studies have provided surprising new insights into the physiological function of 
polyploidization. To gain insight into the possible reasons for polyploidy in vivo is necessary 
to analyze where and when polyploidization occurs during embryonic and postnatal 
development. 
1.3.1. Trophoblast giant cells 
TGCs are the first polyploid cell type during development and their formation occurs during 
implantation of mouse blastocysts at embryonic (E) day E4.5. TGCs differentiate from the 
trophectoderm layer in the blastocyst, are endocrine in nature, and are composed of an 
extremely large cytoplasm and polyploid nuclei. TGCs undergo multiple rounds of 
endoreplication and thereby accumulate DNA up to 1000C (Lee et al. 2009; Edgar et al. 
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2014). The physiological significance of polyploidization for TGC function is a matter of 
speculation (Lee et al. 2009; Pandit et al., 2013). Because TGC have a relatively short 
lifespan, it may be that polyploidization and the associated hypertrophy allow tissue growth 
with less time and energy expenditure. Another hypothesis is that polyploidization is 
important for the terminal differentiation of TGC. Polyploidy may increase their capacity for 
protein synthesis because TGC secrete a wide array of hormones and paracrine factors, 
including steroid hormones and prolactin related cytokines (Hu & Cross 2010). Furthermore, 
polyploidization through increased gene expression may supply the energy necessary for 
aggressive invasion of TGC into maternal tissue.  
As mentioned above, Cyclin E1/E2, Cdh1, or Dp1 deficiency in mice results in 
embryonic lethality at E10.5–11.5 with marked reduction of polyploidization in TGCs (Geng 
et al. 2003; Parisi et al. 2003; Garcia-Higuera et al. 2008; Kohn 2003). Mutant Cyclin E1/E2 
TGCs show equal expression of differentiation markers compared to wild type TGCs, 
indicating that polyploidization and TGC differentiation are not causally linked. Interestingly, 
embryonic lethality is rescued by providing cyclin E or Cdh1 mutant embryos with a wild 
type placenta, suggesting that the polyploidization defect in these mutant TGCs is the main 
cause of embryonic lethality. However, TGC-specific deletion of these molecules would be 
required to appropriately address this hypothesis.  
1.3.2. Megakaryocytes 
Megakaryocytes are a second example of developmentally regulated polyploidization in 
mammals (Ravid et al. 2002; Thon & Italiano 2012; Machlus & Italiano 2013). The first 
polyploid megakaryocyte in mice appears around embryonic day E7.5 in the blood islands of 
the yolk sac (Xu et al. 2001). Megakaryocytes differentiate from hematopoietic stem cells in 
response to the cytokine thrombopoietin (TPO) (Kaushansky 2009) and at later stages of 
embryonic development megakaryocytes can be found in the liver, bone marrow, and spleen. 
Megakaryocytes give rise to platelets (thrombocytes; Figure 1.7), which are essential for 
blood clotting and angiogenesis.  
Proplatelets can been observed extending from megakaryocytes in the bone marrow 
through junctions in the lining of blood sinuses where they have been hypothesized to be 
released into the circulation and undergo additional fragmentation into platelets (Patel et al. 
2005). For proplatelet formation is necessary a complete transformation of the cytoplasm. The 
transformation unfolds over 3 to 10 hours and begins in a polarized fashion with the erosion 
of one side of the megakaryocyte cytoplasm (Figure 1.7). Thick pseudopodia-like processes 
initially form and then extend into thin tubes of uniform diameter of 2 to 4 μm. The thin 
tubules subsequently undergo a dynamic bending and branching process and develop periodic 
platelet-sized swellings that span their length (Figure 1.7). Proplatelet formation and 
elongation is dependent on microtubule function. Ultimately, the megakaryocyte is converted 
into a residual naked nucleus surrounded by an elaborate network of proplatelets. 
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Figure 1.7. Production of platelets by megakaryocytes. As megakaryocytes transition from immature 
cells (A) to mature structures able to release platelets (E), a systematic series of events occurs. (B) The 
cells first undergo nuclear endomitosis, organelle synthesis, and dramatic cytoplasmic maturation and 
expansion, while a microtubule array, emanating from centrosomes, is established. (C) After 
polyploidization of megakaryocytes and prior to the onset of proplatelet formation, centrosomes 
disassemble and microtubules translocate to the cell cortex. Proplatelet formation commences with the 
development of thick pseudopods. (D) Sliding of overlapping microtubules drives proplatelet elongation as 
organelles are tracked into proplatelet ends, where nascent platelets assemble. Proplatelet formation 
continues to expand throughout the cell while bending and branching amplify existing proplatelet ends. (E) 
The entire megakaryocyte cytoplasm is converted into a mass of proplatelets, which are released from the 
cell. The nucleus is eventually extruded from the mass of proplatelets, and individual platelets are later 
released from proplatelet ends. Source: (Patel et al. 2005). 
The subsequent rupture of the cytoplasmic bridges between platelet-size segments is 
thought to release individual platelets into the circulation (Figure 1.7). It has been suggested 
that the large size of megakaryocytes and their high ploidy are essential for the release of 
thousands of enucleated platelets per cell (Kaushansky 2009). Accordingly mice deficient for 
TPO (de Sauvage et al. 1996) or for its receptor (Alexander et al. 1996) presented 
megakaryocytic hypopolyploidization that perfectly correlated with severe thrombocytopenia 
(low blood platelets levels). Similarly deficient mice for the stem cell leukemia factor 
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(SCL/TAL1), specifically in megakaryocytes, were profoundly thrombocytopenic due to 
aberrant polyploidization and maturation of megakaryocytes (Chagraoui et al. 2011). 
1.4. Requirements for cell cycle regulators in endomitosis, 
megakaryocyte maturation and platelet formation 
1.4.1. Cell cycle regulators in endomitotic process 
The relevance of known cell cycle regulators during endomitosis has been a matter of 
speculation, and only few analysis of loss- or gain-of-function have been performed. 
Examination of the cyclin expression profile in both megakaryocytic cell lines and primary 
megakaryocytes has shown that Cyclin E, D3, and to a less extent cyclin D1, are expressed 
and upregulated upon treatment to ploidy-promoting factors such as TPO (Zimmet et al. 1997; 
Eliades et al. 2010). Importantly Cyclin D3 overexpression in megakaryocytes resulted in 
higher ploidy while overexpression of cylin D1 only provoked moderate increase in ploidy 
(Zimmet et al. 1997). Interestingly overexpression of Cyclin D1 was sufficient to rescue the 
polyploidization defects in megakaryocytes deficient for GATA-1, an essential transcription 
factor during megakaryopoiesis (Muntean et al. 2007). However, no significant differences 
were detected when cyclin D1 deficient mice were analyzed for mekagaryocytic 
polyploidization. This lack of phenotype was speculated to be due to a possible compensatory 
role of cyclin D3 since it was found highly upregulated in megakaryocytes deficient for cyclin 
D1 (Muntean et al.  2007). 
E-type cyclins have also been found to play an important role during polyploidization. 
Cyclin E1 and E2 double knock-out mice showed impairment of polyploidization in 
megakaryocytes (Geng et al. 2003). Accordingly overexpression of cyclin E specificaly in 
megakaryocytes led to enhanced ploidy both in vivo and in vitro comparable to levels 
achieved by TPO administration (Eliades et al. 2010). 
While both p53 and p21Cip1 have been reported to be expressed in endomitotic 
megakaryocytes, deficiency for these proteins did not affect either megakaryocyte 
polyploidization or platelet production in vivo (Fuhrken et al. 2008; Apostolidis et al. 2012; 
Baccini 2001).  Interestingly in vitro ablation of p53 in hematopoietic progenitors during its 
differentiation towards megakaryocytes resulted in higher ploidy megakaryocytes because of 
greater entry into S-phase and less induction of apoptosis (Apostolidis et al. 2012). 
Accordingly while p21Cip1 is not essential for the determination of the ploidy profile in 
normal megakaryocytes in vivo, overexpression of p21Cip1 caused the arrest of the 
endomitotic cycle (Baccini 2001). 
The implication of mitotic regulators and, specifically, Aurora B in the endomitotic 
cycle has been a matter of debate. Aurora B kinase is a member of the CPC that changes its 
subcellular localization during mitosis (Carmena et al. 2012). Aurora B is associated with 
chromosomes during prophase, with inner centromeres during metaphase and early anaphase, 
Introduction 
 
34 
 
and with the midzone and midbody during late anaphase and telophase. Aurora B activity 
depends on its association with other chromosome passenger proteins (INCENP, Borealin, 
and survivin) as well as its autophosphorylation at threonine 232 (Thr232) located in the 
activating loop (Carmena et al. 2012). Aurora B is involved in chromosome congression at 
metaphase and chromosome separation at anaphase. In addition is essential for mitosis and 
cytokinesis since its ablation provokes premature mitotic exit and cytokinesis failure 
(Fernández-Miranda et al. 2011; Trakala et al. 2013). Accordingly it has been shown that 
Aurora B kinase exerts its role in cytokinesis by regulating mitotic kinesin-like protein 1 
phosphorylation, which controls the abscission checkpoint to prevent tetraploid cell 
occurrence (Guse et al. 2005; Steigemann et al. 2009).  
In endomitotic cell cycles it was initially shown that Aurora B was not expressed or only 
at a low level in murine megakaryocytes, and it was postulated that this deregulated 
expression was responsible for polyploidy (Kawasaki et al. 2001; Zhang et al. 2004). 
Subsequently, it was shown that Aurora B is not only expressed and functional during the 
early endomitosis phases of human megakaryocytes but also all along the endomitosis and 
whatever the ploidy (Geddis & Kaushansky 2004). Interestingly while chemical inhibition of 
in vitro megakaryocytic cultures did not alter polyploidization it did induced growth arrest 
and apoptosis in 2C and 4C megakaryocytic precursors during mitosis (Lordier et al. 2010). 
Importantly when Aurora B overexpression was induced in megakaryocytes no dramatic 
changes in polyploidization were observed (Nguyen et al. 2005). Similar results were 
obtained during the specific ablation of Survivin, another CPC component (McCrann et al. 
2008; Wen et al. 2009; Ravid 2009). 
1.4.2. Mastl and human thrombocytopenia 
Mastl (Microtubule-Associated Serine/Threonine protein kinase-Like) is an additional cell 
cycle kinase recently characterized kinase because of its critical functions in the maintenance 
of mitosis (Figure 1.8) (Malumbres 2011; Glover 2012). Mastl, also known as Scant or 
Greatwall, was originally discovered in Drosophila screenings for cell cycle mutants 
(Archambault et al. 2007; Yu et al. 2004). Deficiency in this kinase leads to defective 
chromosome condensation and segregation in mitosis and this phenotype is due to 
hyperactivation of PP2A-B55 complexes (Vigneron et al. 2009; Yu et al. 2004; Álvarez-
Fernández et al. 2013). In fact, Mastl is known to exert its role through phosphorylation of 
endosulfine and Arpp19, two small proteins that function as PP2A-B55 inhibitors (Figure 
1.8)(Gharbi-Ayachi et al. 2010; Mochida et al. 2010). 
PP2A is a heterotrimeric serine-threonine phosphatase composed of a catalytic subunit 
C, a structural subunit A and a regulatory subunit B, which confers substrate specificity.  In 
mammals, there are 4 subfamilies of B regulatory subunits (B55, B56, PR72 and PR93), each 
one with multiple isoforms. In particular, depletion of PP2A-B55 complexes delays mitotic 
exit and postmitotic reassembly of various interphase structures (Schmitz et al. 2010). In 
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agreement with that, Cdc20-null cells arrest in metaphase and require both Cdk inactivation 
and the activity of PP2A-B55 phosphatase complexes to exit from mitosis (Manchado, et al. 
2010). Little is known about the mammalian Mastl ortholog although its inhibition also 
results in defects in mitotic progression and mitotic exit in a PP2A-B55-dependent manner 
(Burgess & Vigneron 2010; Manchado et al. 2010; Voets & Wolthuis 2010; Álvarez-
Fernández et al. 2013) 
Independent of these studies a missense mutation was found in 2003 in a region of 
human chromosome 10p11-12 in patients with nonsyndromic autosomal dominant 
thrombocytopenia, also known as thrombocytopenia-2 (THC2) (Gandhi et al. 2003). These 
patients were characterized by incomplete differentiation of megakaryocytes and mild 
thrombocytopenia with an average platelet count of 60,000 platelets per microliter of blood. 
The mutation, a substitution of cytosine for guanidine (G to C) at nucleotide position 565, was 
present in all thrombocytopenic family members, causing a predicted substitution of aspartic 
acid for glutamic acid (E167D) in exon four of the FLJ14813 sequence (Gandhi et al. 2003). 
Using morpholino knockdown assays in zebrafish, it was shown that knockdown of Mastl in 
the embryo resulted in deficiency in circulating thrombocytes (Johnson et al. 2010). In 
addition to the E167D substitution in MASTL, additional mutations in two genes in the THC2 
region of chromosome 10p11-12 have been recently linked to congenital thrombocytopenia. 
These include specific mutations in ACBD5 and the 5' UTR of ANKRD26, the ankyrin repeat 
domain 26 gene (Pippucci et al. 2011). These three genes are very close in human 
chromosome 10p12.1 (ACBD5-MASTL-YME1L1-ANKRD26; centromeric to telomeric) and 
the relative contribution to thrombocytopenia is still under debate (Di Paola and Johnson, 
2011; Pippucci et al., 2011). However, the role of Mastl in this process and its possible links 
to cell cycle regulation are currently unknown. 
 
 
Figure 1.8. Role of Mastl as an 
inhibitor of PP2A phosphatases. 
Mastl is activated in a Cdk-dependent 
manner and phosphorylates members of 
the Ensa family. These small molecules, 
when phosphorylated, bind and inhibit 
PP2A-B55 complexes. Since PP2A-B55 
counteracts Cdk-dependent 
phosphorylations during mitosis, Mastl 
function as a critical enzyme to support 
Cdk-dependent phosphorylations during 
mitosis. 
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 1.4.3 Gene modulation specifically in megakaryocyte and platelets  
Constitutive and ubiquitously gene expression or ablation often results in severe phenotypes 
that interfere with the analysis of particular cell types or tissues or can mislead due to 
compensatory mechanisms. This also has been the case for the megakaryocytic compartment. 
While mouse models mentioned above gave insights into the requirements of those regulators 
during endomitosis still those results were difficult to interpret due to its effect on the whole 
hematopoietic system. In order to overcome these limitations, the generation of mouse models 
that allow gene modulation specifically in the tissue or cell type of interest, are crucial. To 
date tool mouse models exist that can be used for this purpose. Specific promoters for 
megakaryocytes and platelets such as the platelet factor 4 (Pf4) have been successfully driven 
the expression either of Cre recombinase or any other transgenes (Tiedt et al. 2007; Nguyen et 
al. 2005). These models will be crucial for addressing the questions addressed in this work. 
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Objectives of the work 
 
The current study aims to investigate the physiological relevance and the molecular basis of 
polyploidization and the requirements of well-known cell cycle regulators during this process. 
For this purpose we will focus on the megakaryocytic example to perform our studies. 
Investigating the endomitotic polyploidization that megakaryocytes undergo will help us not 
only to understand better basic biological perspectives of the cell cycle but also how we can 
modulate megakaryocytic polyploidization as therapeutic strategies for pathological 
conditions related to hepatopoietic system such as thrombocytopenia and thrombocytosis as 
well as megakaryoblastic leukemia.  
 
The objectives we propose are 
 
 
1. Deciphering the function of Mastl in platelet formation by generating and 
characterizing a mouse model for the human thrombocytopenia syndrome. 
 
2. Investigate the relevance of kinases needed for mitotic progression such as Aurora B, 
Plk1 and Mastl during the endomitotic process. 
 
3. Understand the requirements for the APC/C during the endomitotic cycles. 
 
4. Examine the requirements for cyclin-dependent kinases (Cdks) for entry into 
endomitosis. 
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3.1. Genetically modified mouse models 
3.1.1. Animal housing 
Mice were housed in the pathogen-free animal facility of the Centro Nacional de 
Investigaciones Oncológicas (CNIO, Madrid) following the animal care standards of the 
institution. These animals were observed on a daily basis and sick mice were killed humanely 
in accordance with the Guidelines for Humane End Points for Animals used in biomedical 
research. All animal protocols were approved by the ISCIII committee for animal care and 
research. All animals were maintained in a mixed 129/Sv (25%) x CD1 (25%) x C57BL/6J 
(50%) background 
3.1.2. Generation of mouse models 
For the generation of the Mastl knock-in mouse we replaced the wild-type allele with an allele 
carrying the E166D mutation described in the human thrombocytopenia syndrome (Drachman 
et al. 2000; Gandhi et al. 2003) employing a targeting vector constructed by Gene Bridges. A 
conditional loss-of-function model of Mastl was also generated in our laboratory by flanking 
exon 4 of the murine Mastl locus with loxP sites and a selection cassette consisting of the 
PGK promoter and the neo/km resistant gene flanked by frt sites (Álvarez-Fernández et al. 
2013). To facilitate homologous recombination, mouse ES cells V6.4 obtained from a hybrid 
(129 x C57BL/6J) strain were electroporated with 100 g of linearized DNA from the 
corresponding targeting vectors. Recombinant ES cells and clones were selected in the 
presence of G418 (neomycin). This step was done by the Transgenic Unit of the CNIO. The 
screening of the recombinant clones was performed by Southern blot analysis using new 
restriction sites from the recombinant alleles and probes external to the homology arms. 
Positive recombinant clones were either aggregated with morulas CD1 or microinjected into 
C57BL/6J blastocysts by the Transgenic Unit of the CNIO. The resulting quimeric mice were 
crossed with Actin-Flp transgenic mice to generate Mastl(+/E166D) mice. 
Pf4-Cre transgenic mice (Tiedt et al. 2007) were obtained by the Jackson laboratories in 
a pure C57BL/6J background. The transgenic mouse line expressing the far-red fluorescent 
protein Katushka, driven by the hybrid CAG promoter upon Cre-mediated recombination 
[(lox-Stop-Lox-KFP (Diéguez-Hurtado et al. 2011)] was obtained by Dr. Ortega’s laboratory. 
Aurora B-, Cdh1-, Cdc20- conditional knockouts and Cdk2 knockout mice were reported 
previously and were obtained from M. Barbacid’s lab or from our laboratory (Fernández-
Miranda et al. 2011; Garcia-Higuera et al. 2008; Manchado, et al. 2010; Ortega et al. 2003). 
Cdk1 and Plk1 conditional knockout animals were obtained from Dr. Barbacid´s laboratory or 
generated by P. Wachowicz in our laboratory (unpublished work), respectively.  
For genotyping alleles for the several mouse models we isolated tail DNA from 3-4-
week old mice and we performed a PCR amplification reaction using the oligonucleotides 
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shown in Table 2.1 and following this conditions: 94ºC during 4 minutes followed by 35 
cycles of DNA denaturalization at 94ºC during 30 seconds, primer annealing at 60ºC during 
30 seconds and polymerase extension at 72ºC during 60 seconds ending with a single 
elongation cycle of 7 minutes at 72ºC. 
 
Table 2.1. Mouse models analyzed in this work and oligonucleotides used for mouse genotyping in PCR 
Mouse Model Allele Size (bp) Sequence (5´-3) 
Aurbk conditional knockout 
Aurkb(+) 
Aurkb(lox) 
358 
491 
Fw: AGGGCCTAATTGCCTCTTGT 
Rv: GGGCATGAATTCTTGAGTCG 
Mastl conditional knockout 
Mastl(+) 
Mastl(lox) 
296 
408 
Fw: GCCCTTTTAAAAACCCAACA 
Rv: GGCTGGCAGTTCCATTTTTA 
Mastl knock-in 
Mastl(+) 
Mastl(E166D) 
296 
408 
Fw: GCCCTTTTAAAAACCCAACA 
Rv: GGCTGGCAGTTCCATTTTTA 
Cdh1 conditional knockout 
Cdh1(+) 
Cdh1(lox) 
168 
286 
Fw: AGCATGGTGACCGCTTCATCC 
Rv: GCTGGGGGACTTCTCATTTTCC 
Cdc20  conditional knockout 
Cdc20(+) 
Cdc20(lox) 
500 
670 
Fw: GATTTGCACTCACTGCTTCAACTGG 
Rv: CTTTCTGATGCTCCTGAAATACACG 
Cdk1 conditional knockout 
Cdk1(+) 
Cdk1(lox) 
650 
800 
Fw: GAGATGTAGGATGACTCAGTG 
Rv:  TAGCTTATCTACCTCAGCCTG 
Cre transgenic Pf4-Cre 450 
Fw: CCCATACAGCACACCTTTTG 
Rv: TGCACAGTCAGCAGGTT 
Cre reporter KFP-LSL 812 
Fw: AACGACCACCACTTCAAGTGC 
Rv: TAGCCAGAAGTCAGATGCTCAAGG 
3.1.3. Histology 
For histology sections, sterna and spleens were fixed overnight in 4% formalin. Sterna were 
then decalcified in Decalcifier I solution (Surgipath) for 2 hours. Specimens were dehydrated 
in 70% ethanol and processed by the Histopathology Facility Unit at CNIO for 3-5 m 
longitudinal paraffin sections, hematoxylin and eosin staining, and immunohistochemistry for 
von Willebrand Factor, phospho-histone H3 (ser10) or gamma-H2AX (H2AX). To quantify 
megakaryocytes in bone marrow and spleen, paraffin sections stained with anti-VWF were 
examined using an Olympus BX51 microscope equipped with objective lenses (40/0.75, 
20/0.4, 10/0.25, and 4/0.1). Total megakaryocyte number was counted in each 4X observation 
field 
3.1.4. Isolation of megakaryocytes from the bone marrow 
CD41+ cells were enriched from bone marrow by the MACS (magnetic cell shorting) cell 
separation system (Miltenyi Biotec). Bone marrow cells were exposed to FITC-CD41, and 
mixed with anti-FITC microbeads (Miltenyi Biotec). The associated cells were separated 
using a large cell separation column (Miltenyi Biotec). However, contaminating non-
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megakaryocytic cells could not be completely removed by this method. CD41-enriched cells 
were immunostained with FITC-CD41 (Biosciences) antibody.  
3.2. Cell Culture 
3.2.1. Bone marrow-derived megakaryocytes 
Tibia and femur were isolated from 8-12 week old mice and bone marrow was flushed out by 
the addition of ice-cold PBS buffer (PBS, 0.5% BSA, 5mM EDTA) through the lumen of the 
bone. Marrow was mechanically disrupted to achieve single cell suspension followed by 
filtering through a 40mm nylon strainer to remove bone debris and subsequently subjected to 
erythrocyte lysis. For red blood cell lysis the bone marrow cell pellet from 1 mouse was 
resuspended in 1 ml of ACK lysis buffer (150 mM ammonium chloride, 1 mM potassium 
bicarbonate, 0.1 mM EDTA) and incubated for 1.5 min on ice. The lysis was stopped by the 
addition of 10 ml PBS buffer and cells were centrifuged at 200g for 10 min. Cells were 
counted and subjected either directly to surface antigen staining for flow cytometry analysis 
(FACS) or to lineage depletion MACS cell separation system (Miltenyi Biotec) with the 
Hematopoietic Progenitor (Stem) Cell Enrichment Set, according to manufacturer’s protocol. 
Lin- isolated cells were grown in Dulbecco‟s modified Eagle’s medium (DMEM; Gibco) 
supplemented with antibiotics and 10% fetal bovine serum (FBS) supplemented with 50 
ng/ml murine thrombopoietin (TPO), (PeproTech). 
3.2.2. Fetal liver-derived megakaryocytes 
Fetal liver cells were obtained from whole livers recovered from mouse fetuses between 
embryonic days 12.5 and 13.5. Single-cell suspensions were prepared by successive passage 
through 19-, 22-, and 25-gauge needles and cultured in Dulbecco’s modified Eagle’s medium 
supplemented with 10% fetal bovine serum, penicillin/streptomycin, and 100 ng/mL murine 
TPO for 5 days. After 4 to 5 days of culture in the presence of TPO, the cell population was 
en- riched in mature megakaryocytes using a 1.5%/3% bovine serum albumin (BSA) gradient 
under gravity (1g) for 45 minutes at room temperature. 
3.2.3. Mouse embryonic fibroblasts (MEFs) 
Mouse embryonic fibroblasts (MEFs) were prepared from E14.5 embryos and cultured using 
standard protocols. E14.5 embryos were extracted from the uterus of pregnant females. The 
placenta was removed and embryos were isolated from the yolk salk. The embryo without the 
liver and the head was minced, and dispersed in 0.1% trypsin (5 min at 37°C). Cells were 
grown for two population doublings and then frozen. All cultures were maintained in 
Dulbecco’s modified Eagle’s medium (DMEM; Gibco) supplemented with 1% 
penicillin/streptomycin and 10% fetal bovine serum (FBS). MEFs transduction was 
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performed using adenoviruses expressing Cre recombinase (Ad5 CMV-Cre) obtained from 
The University of Iowa (Iowa City, IA). Transduction was carried out either in presence or 
absence of serum. MEFs transfection was carried out using the Neon technology (Life 
Technologies; Invitrogen)  
3.2.4. Human cell lines 
HEK293 and U2OS were maintained in DMEM medium supplemented with 10% fetal bovine 
serum and antibiotics and were grown at 37ºC in a humidified 5% CO2 atmosphere. HEL 
(human erythroleukemia cell line) were grown in RPMI (Roswell Park Memorial Institute 
medium) supplemented with 10mM Hepes with 10% fetal bovine serum and antibiotics. 
Plasmid transfection in HEK293 and U2OS cells was performed using Lipofectamine 2000 
(Invitrogen).  
3.2.5. Virus production and cell transduction 
Lentiviruses and retroviruses were produced and concentrated as previously described 
(Tiscornia et al. 2006). Briefly low passage 293T cells were transfected with the vector of 
interest and the three packaging vectors expressing gag, pol and rev proteins necessary for 
virion production as well the envelope protein vsvg. 48 hours post transfection supernatants 
containing viruses were collected and concentrated by centrigufation at 19400 rpm for 2 hours 
at 20ºC. Viral pellets were resuspended in 1x HBSS. This viral preparation is of in vitro grade 
quality. For retroviruses 293T cells were transfected with the vector of interest and the 
packaging vector PCL-Eco. Supernatants were collected and 48 hours post transfection. 
Packaging vectors are a gift from Dr. Verma´s lab. 
Transduction of primary megakaryocytes and Lin- bone marrow cells were performed 
by adding 10ml of concentrated virus (stock 109/ml viral particles) per million of cells (MOI 
10) for 12 hours or by using directly the viral supernatants collected from 293T cells 
repeating three times for 6hours always in presence of 50ng/ml TPO. Transduction of HEL 
cell line was performed by viral supernatants twice. 
3.3. Flow cytometry 
Flow cytometric analysis of DNA content and surface markers of megakaryocytes was 
determined by staining either whole bone marrow cells or hematopoitic progenitors cultures 
from 0-5 days in presence of TPO with fluorescein isothiocyanate (FITC)–conjugated anti-
CD41 antibody (BD Biosciences) followed by fixation with 4%PFA at room temprature (RT) 
for 30 min followed by staining with DAPI 2 mg/ml (Sigma-Aldrich) for at least 1hour. 
To determine mouse bone marrow HSC (Lin- IL7R- c-kit+ Sca+), CLP (Lin- IL7R+ c-kit+ 
Sca+), CMP (Lin- IL7R- c-kit+ Sca- CD34+, FcRlow), MEP (Lin- IL7R- c-kit+ Sca- CD34-, 
Materials and Mehods 
47 
 
FcRlow), GMP (Lin- IL7R- c-kit+ Sca- CD34+, FcRhigh), and megakaryocyte progenitor (Lin-
CD41+) cells, freshly obtained BM cells were stained with phycoerythrin (PE) anti-CD34 (BD 
Biosciences), Alexa Fluor 488 anti- IL7Ra,  peridinin chlorophyll Protein Cyanin 5.5 (PerCP-
Cy 5.5 anti–Sca-1, allophycocyanin-H7 (APC-H7) anti-cKit (BD Biosciences), 
phycoerythrin-cyanin 7 (PE-Cy 7) anti-FcR (BD Biosciences) and  allophycocyanin (APC) -
labeled lineage cell detection cocktail (BD Biosciences). Flow cytometric analysis was 
performed with a FACS-Canto flow cytometer or a LSRII flow cytometer (BD Biosciences) 
and FlowJo Version 8.8.7 software (TreeStar). 
3.3.1. Flow cytometric analysis of CD42 (GPIbα)  
Whole blood was obtained by puncturing the right ventricle of euthanized mice. Blood was 
anticoagulated by collecting into a 1/10 volume of 3.8% (w/v) sodium citrate solution. 
Platelet rich plasma (PrP) was isolated by centrifuging whole blood at low speed (180 x g, 10 
min, RT). After centrifugation, the supernatant was washed and resuspended in Plt-HEPES-
ACD buffer (137 mM NaCl, 2 mM KCl, 0.4 mM NaH2 PO4, 1 mM MgCl2, 1 mM CaCl2 and 
10% (w/v). Platelets in PRP were stained with APC-conjugated anti-CD42 mAb (GPIbα, 
Bioscience)  
3.4. Live cell imaging 
Primary megakaryocytes derived from bone marrow hematopoietic progenitors were 
subjected to long-term, time-lapse imaging using a computer- assisted microscope. Cells were 
prepared as previously described and after 48 or 72hours upon TPO addition and/or viral 
transduction were plated on eight-well glass-bottom dishes (Ibidi) embedded in 
methylcellulose containing Iscove's Modified Dulbecco's Medium (IMDM) with 2% Fetal 
Bovine Serum and 100ng/ml murine TPO in order to minimize cell movement. Time lapse 
acquisition was performed with a Leica DMI 6000B microscope equipped with a 63×/1.5 
N.A. objective lens or DeltaVision RT imaging system (Applied Precision; IX70/71; 
Olympus) equipped with a Plan Apochromatic 40×/1.42 N.A. objective lens, and maintained 
at 37°C in a humidified CO2 chamber. Images were acquired every 7 min for up to 10 days. 
Quantitative analysis was performed by ImageJ software. 
3.5. Biochemical procedures 
3.5.1. Protein extraction and analysis 
For immunodetection in protein lysates, cells were washed twice with ice-cold PBS and lysed 
in RIPA lysis buffer (37 mM NaCl, 0.5% NP-40, 0.1% SDS, 1% TX-100, 20 mM Tris-HCl 
pH 7.4, 2 mM EDTA, 10% glycerol 1 mM PMSF) supplemented with protease and 
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phosphatase inhibitory cocktails (Sigma). After 30 min on ice, samples were cleared by 
centrifugation. Proteins were separated on SDS-PAGE, transferred to nitrocellulose 
membranes (BioRad), and probed using specific primary antibodies noted as WB in Table 
2.2. Secondary antibodies were coupled to HRP (DAKO) for immunodetection. 
3.5.2. Immunoprecipitation and in vitro kinase assays 
Total protein lysates were precleared with protein G-agarose bead suspension for 1hour 
(Amersham). Supernatants were first incubated for 2h at 4ºC on a rotating wheel with the 
primary antibody and later with 50 ml of the blocked bead suspension for an additional hour. 
Immunoprecipates were washed three times in RIPA buffer and once in kinase assay buffer 
[10 mM HEPES-NaOH (pH 7.4), 150 mM NaCl, 10 mM MgCl2, and 1 mM EGTA] 
supplemented with 0.5 mM DTT and phosphatase inhibitor cocktail (Calbiochem) and later 
incubated in 25 μl of 2x kinase buffer supplemented with 0.2 mM ATP, 2.5 uCi [-32P] ATP 
and 3 mg of MBP as substrate. The reactions were incubated for 30 min at 30° C, stopped by 
addition of 5 μl of 5x Laemmli sample buffer, separated on a 12% SDS-PAGE and analyzed 
by autoradiography. 
3.5.3. Immunofluorescence 
Adherent cells grown on cover-slips and megakaryocytes after cytospin were fixed with 4% 
paraformaldehyde in PBS for 10 min at 37 oC, permeabilized with PBS-Triton 0.15% for 2 
min at 37oC, blocked with 3% BSA and subsequently incubated with the primary antibodies 
noted as IF that are shown in Table 2.2 for 1 to 3 hours. The matching secondary antibodies, 
with different Alexa dies (488, 594, 647) and DAPI for nuclei visualization are from 
Molecular Probes (4,6 diaminophenylindole, Prolong Gold antifade; Invitrogen). Image 
acquisition was performed using either a confocal ultra-spectral microscope (Leica TCS-SP5) 
or a Leica DMI fluorescence 6000B microscope. 
3.6. DNA combing 
For the analysis of DNA replication in stretched DNA fibers, cells were incubated in presence 
of 50µM CldU (5-Clorodeoxyuridine) for 2 hours at 37oC, followed by three washes in warm 
PBS for 5 min each. Subsequently cells were pulsed for 30 min with 250 IdU (5-
Iododeoxyuridine). One drop containing 500-700 cells was placed on a microscope slide and 
cells were lysed with the addition of 10µl lysis buffer [0.5% SDS, Tris (pH 7.4), EDTA 
50mM] for 6 min in RT. Slides were tilted at a 10-15o angle to allow the DNA suspension to 
run slowly down the slide. Slides were air-dried and fixed in 3:1 v/v methanol:acetic acid. 
Following DNA denaturation with 2.5M hydrochloric acid for 30 min, DNA fibers were 
washed and blocked with PBS, 1%BSA, 0.1% Triton X-100 for 1 hour in RT and incubated 
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with primary antibodies against CldU and IdU. Matching secondary antibodies, with different 
Alexa dies (488, 594, 647) were used for signal visualization. Image acquisition was 
performed using a Leica DMI fluorescence 6000B microscope. For each sample were 
performed at least 500 measurements for origin firing. 
 
Table 2.2. Primary antibodies used in different assays: immunohistoquemistry (IHQ), Immunofluorescence 
(IF), Immunorecipitation (IP) and Western blot (WB) 
Antibody Host Species Application Dilution Source/Clone 
AKT Rabbit WB 1:500 Cell Signaling 
-tubulin Mouse IF, WB 1:2000 Sigma / DM1A 
Aurora B Rabbit IF 1:200 Abcam 
Cyclin B1 Rabbit WB  1:500 
Santa Cruz 
Biotech 
Cdk1 Rabbit WB 1:500 
Santa Cruz 
Biotech 
Erk 1/2 Rabbit WB 1:1000 Cell Signaling 
Mastl Mouse WB, IP 1:500/1:100 
ABGENT/ 
RB35078 
Phospho- (ser) Cdk 
substrate  
Rabbit WB 1:500 Cell Signaling 
Psopsho-Erk 1/2 
(Thr202/Tyr204) 
Rabbit WB 1:1000 Cell Signaling 
Phospho-Histone 
H3 (Ser10) 
Rabbit IF, IHQ 1:500/1:2000 
Upstate 
Biotechnology 
Phospho-Histone 
H2A.X (Ser139) 
Mouse IHQ  1:2000 
Millipore / 
JBW30 
Vinculin Mouse WB 1:5000 Sigma 
Von Wilebrand 
Factor 
Mouse IHQ 1:2000 Millipore 
 
3.7. Statistical analysis 
Statistical analysis was carried out using Prism 5 (GraphPad). All statistical tests were 
performed using two-sided, unpaired Student’s t-tests, or the Fisher’s exact test. Data with 
p<0.05 were considered statistically significant. In most figures, *, p<0.05; **, p<0.01; ***, 
p<0.001.  
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4.1. A role for Mastl in megakaryopoiesis and platelet formation  
4.1.1. A new mouse model for thrombocytopenia  
Given the presence of mutations in MASTL in human thrombocytopenia, we initially focused 
on the analysis of the requirements for this kinase during endomitosis and platelet formation. 
To this end, we generated two mutant mice strains with specific alterations in the 
corresponding murine locus. We first generated a knockin allele carrying the ortholog 
mutation found in human thrombocytopenic patients (E167D; corresponding to E166D in the 
mouse; Mastl(E166D); Figure 4.1). Second, we generated a mouse strain with specific 
ablation of Mastl in megakaryocytes. Since homozygous germline ablation of Mastl [Mastl(–
/–)] results in early embryonic lethality we made use of a conditional allele [Mastl(lox)] 
recently generated in our laboratory (Álvarez-Fernández et al. 2013) in which exon 4, 
carrying essential domains for kinase activity, can be deleted upon activation of Cre 
recombinase. We decided to specifically ablate it in mature megakaryocytes by crossing 
Mastl(lox/lox) mice with transgenic mice expressing Cre recombinase under the Pf4 promoter 
(Tiedt et al. 2007). Mutant mice carrying this null allele [Mastl()] specifically lack Mastl 
expression in megakaryocytes and platelets (Figure 4.1).  
Mastl(E166D/E166D) [from now on Mastl(D/D)] were viable and fertile and displayed 
no overt abnormalities during the first months of life suggesting that the E166D mutation 
does not lead to a complete loss of function protein. Since acute ablation of Mastl in 
fibroblasts leads to severe mitotic defects and impaired growth we decided to isolated and 
characterize MEFs from Mastl(D/D) to further analyze any intrinsic effect of  the E166D 
mutation on Mastl activity. 
 
Figure 4-1. Mastl mutant mice. Mastl locus 
encoding Mastl contains 12 exons. The exon 4 
which encodes the critical ATP-binding site for 
the kinase activity was flanked by loxP sites 
(triangles) and a selection cassette [Mastl(loxfrt) 
allele]. Cre-mediated recombination conditionally 
induced results in the Mastl(Δ) null allele. For 
the generation of the thrombocytopenia mouse 
model, exon 4 bearing the E166D mutation was 
followed by a selection cassette flanked by frt 
sites. Site-specific recombination by Flp results 
in the Mastl(E166D) or Mastl(D) allele. 
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Figure 4.2. Analysis of Mastl(D/D) MEFs. (A) Mastl(+/+) and Mastl(D/D) primary MEFs expressing H2B-
GFP were recorded by time lapse microscopy and the duration of mitosis were analyzed upon DMSO or 
Nocodazole (3,2 M). Each dot represents an individual cell (N=30 per group). P>0.05, Student’s t test. (B) 
Mastl(+/+) and Mastl(D/D) primary MEFs were synchronized at G0 by serum depletion and cell cycle entry 
was analyzed for the indicated time points upon seeding cells at low confluence and serum addition (T=0). 
Cell extracts were immunoblotted for phospho-Cdks substrates (p-Cdks), phospho-histone 3 (pH3) and 
cylin B. (C) Western blot analysis of fibroblasts as in (B) in presence of nocodazole. (D) Mitotic shake off of 
primary fibroblasts treated for taxol for 12 hrs. Pure mitotic cells were treated with 50nM of roscovitine in 
presence of taxol and exit from mitosis was monitored by immunoblotting for p-Cdks and cylin B1. Vinculin 
was used as a loading control. 
Mastl(D/D) fibroblasts grew in similar rate compared to Mastl(+/+) MEFs and had a 
similar duration of mitosis either in steady state conditions or with nocodazole treatment 
(Figure 4.2A upper panel) indicating that Mastl E166D does not lead to mitotic defects and 
that is compatible with cell cycling. To assess directly the impact of the mutation on the Mastl 
kinase activity we immunoprecipitated the endogenous Mastl from Mastl(D/D) and 
Mastl(+/+) MEFs and we performed kinase assays using recombinant myelin basic protein 
(MBP) as a substrate. Importantly Mastl E166D showed the same or slightly higher activity 
compared to the wild type Mastl (Figure 4.2A; lower panel). Interestingly when we analyzed 
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cell cycle entry upon serum starvation, either in presence or absence of nocodazole, we 
observed that Mastl(D/D) cells showed higher levels of phospho-Cdks and MAPKs residues 
(a well-established readout for the function of Mastl in the balance between Cdks and PP2A 
in substrate phosphorylation; Figure 4.2B, C). This increase is not because of a higher mitotic 
index since cyclin B1 and pH3 levels were similar in both cell groups. In addition similar 
results were observed when extracts from the same amount of mitotic cells were treated with 
roscovitine in presence of taxol and subsequently subjected to immunobloting for phospho-
Cdks and MAPKs substrates (Figure 4.2D). Overall these assays indicate that the Mastl 
E166D results in a functional gain-of-function rather than a loss of function mutation. 
4.1.2. Mastl role in megakaryopoiesis is cell cycle independent 
We next analyzed blood platelet levels in Mastl mutant mice. Given the variability between 
animals (sex and age dependent) we chose animals between 8 and 12 weeks to perform our 
analysis. Mastl(D/D) 12 weeks-old showed slightly reduced platelets numbers with average 
platelet number of 731 ± 24 (mean ± SEM; more obvious in females than males) although not 
dramatic differences were detected compared to the control mice 874 ± 22 (Figure 4.3A).  
Similar results we found in Mastl() mice although with more pronounced 
thrombocytopenia with average platelet number of 668 ± 43. Interestingly, both Mastl(D/D) 
and Mastl() cohorts analyzed during the whole adult mouse life in different ages (8-100 
weeks) displayed an increased mild thrombocytopenia incidence (animals with blood platelet 
levels less than 800 x 109 platelets/L) although the differences were not significant when 
considering the whole cohort in Mastl(D/D) mice. (Figure 4.3B). 
 
Figure 4.3. Blood platelet levels in Mastl mutant mice (A) Blood platelets levels from 12 week-old 
Mastl(+/+), Mastl(D/D) and Mastl(/) mice. Data represent mean ± SEM; (*, P < 0.05, **, P < 0.01, ***, P < 
0.001. Each dot represents an individual animal. (B) Percentage of mice showing blood platelet levels 
below 800 x103 platelets/mL in the whole cohort of 8-100 week-old Mastl(+/+), Mastl(D/D) and Mastl(/) 
mice. 
Results 
 
56 
 
 
While Mastl(D/D) and Mastl() mice presented no apparent abnormalities in bone 
marrow and spleen indicated by the hematoxylin/eosin (H/E) staining, Mastl() displayed a 
significant defect in the maturation of megakaryocytes in the bone marrow compared to 
Mastl(D/D) and control mice (Figure 4.4A). Megakaryocytic maturation was estimated by 
analyzing the Von Wilebrand Factor (VWF) staining in bone marrow sections, since its 
exclusive expression in megakaryocytes correlates perfectly with their maturation.  
Morfometric analysis of the total, cytoplasmic and nuclear area of VWF+ cells revealed that 
while Mastl(D/D) and control megakaryocytes presented proper maturation Mastl() 
megakaryocytes showed a significant reduction in the total and cytoplasmic area. However 
nuclear area was not significantly different in any of the cell groups indicating no differences 
in megakaryocyte polyploidization (Figure 4.4B). Interestingly Mastl() megakaryocytes 
had a significantly lower cytoplasm to nucleus ratio, a well defined feature of terminal 
megakaryocytic differentiation. 
 
Figure 4.4. Mastl(/) mice present compromised megakaryocyte maturation. (A) Hematoxylin/eosin-
stained bone marrow and spleen sections and immunohistochemical staining for Von Wilebrand Factor 
(VWF). (B) Graphs showing the distribution of area of VWF positive cells based on cytoplasmic, nuclear 
and total area measurements. Each dot represents an individual cell. Total cells analyzed per group (400) 
come from 3 individual animals (n=3). Mice between 8 and 12 week-old were used to perform the 
experiments.  
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Accordingly the percentage of double CD41+CD42+ cells, which represent the more mature 
megakaryocytic population since CD42 expression is a later event during megakaryopoiesis, 
was reduced in the bone marrow of Mastl() mice whereas in the Mastl(D/D) was similar 
to the control mice (Figure 4.5A). In agreement with the similar nuclear area of bone marrow 
megakaryocytes among the different genotypes, Mastl() as well as Mastl(D/D) 
CD41+CD42+ megakaryocytes acquired similar polyploidization levels compared to 
Mastl(+/+) control ones (Figure 4.5B). In addition no defects were detected either in 
hematopoietic progenitors in bone marrow (Figure 4.5C), or in any other mature 
hematopoietic cells in spleen and thymus (data not shown) in any of the Mastl() or 
Mastl(D/D) mice.  Overall these date indicate that Mastl role in platelet formation is related 
with late stages of megakaryopoiesis and thrombopoiesis rather than early cell cycling events 
during endomitosis and thus during polyploidization.  
 
Figure 4.5.  Megakaryocyte polyploidization in Mastl mutant mice. (A) FACS analysis for CD41+CD42+ 
cells from bone marrow and (B) its ploidy distribution estimated by DAPI staining. (C) Percentage of distinct 
subgroups of hematopoietic progenitors from bone marrow by FACS analysis. HSCs (Hematopoetic stem 
cells), CLPs (common lympoid progenitors), CMPs (Common myeloid progenitors), MEPs (megakaryocyte-
erythrocyte progenitors), GMPs (granylocyte-macrophage progenitors). n=5 per group. Data represent 
mean ± SEM; (P > 0.05). Mice between 8 and 12 week-old were used to perform the experiments 
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4.1.3. Mastl role in late events of megakaryopoiesis 
To identify in which specific stages Mastl modulation affects megakaryopoiesis and platelet 
formation, we studied the TPO-induced polyploidization and differentiation of bone marrow 
hematopoietic progenitors (Lin- c-Kit+) towards the megakaryocytic lineage in vitro (Figure 
4.6).  Hematopoietic progenitors upon 24-hour stimulation with TPO (Day1; Figure 4.6A) 
presented a clear 4C polyploid population positive for CD41 while 48 hours later (Day 3) the 
CD41+ cells reached ploidies even higher than 32C (Figure 4.6B). In agreement with the in 
vivo data, hematopoietic progenitors from Mastl(+/+), Mastl() or Mastl(D/D) mice 
showed similar levels of CD41+ cells along differentiation with similar DNA content. In 
addition giemsa staining along differentiation at several days revealed that Mastl(+/+) and 
Mastl(D/D) megakaryocytes after polyploidization around day 5 underwent a maturation 
process prior to platelet shedding as it is indicated by the lighter blue color of the stained 
cytoplasm (Figure 4.6C). 
 
Figure 4.6.  In vitro polyploidization of hematopoietic progenitors upon TPO stimulation. (A) FACS 
analysis for CD41 expression and DNA content by DAPI in bone marrow hematopoietic progenitors (Lin- c-
Kit+) upon TPO stimulation (100 ng/ml) (B) Graph representing the ploidy distribution estimated by DAPI 
staining of the CD41+ cells at day 1 and 3 of differentiation. (C) Giemsa staining in cytospan cells on the 
indicated days of differentiation. Mice between 8 and 12 week-old were used to perform the experiments 
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However Mastl() megakaryocytes although they polyploidized, indicated by the increase 
in the cellular and nuclear size, did not  mature further as it is suggested by the dark blue color 
of the cytoplasmic staining as well as the lack of pro-platelet bearing cells. Interestingly 
further FACS analysis of the cellular complexity (SSC-A) and CD41 expression allowed us to 
identify at late stages of differentiation around day 5 a population completely absent from 
Mastl() megakaryocytes while both Mastl(+/+) and Mastl(D/D) presented (Figure 4.6D). 
Even thought we cannot determine the identity of this population we speculate that represents 
megakaryocytes during the maturation process before platelet release.  
4.1.3. Mastl controls MAPK activity through PP2A regulation 
Mastl is known to exert its function through direct phosphorylation of ENSA and Arpp19 
inhibiting PP2A phosphatase. On the other hand, PP2A is involved in multiple functions in 
megakaryocyte and platelet function (Gushiken et al. 2008; Pawlowski et al. 2002; Wang et 
al. 2008)  . We therefore focused in the analysis of the phosphorylation state of known 
substrates of PP2A that could be involved in platelet formation. Interestingly, Mastl(D/D) 
megakaryocytes isolated from the bone marrow displayed a significant increase in the 
phosphorylation of mitogen-associated protein kinases (Erk), and less significantly of Akt 
kinases while Mastl() megakaryocytes showed a slight reduction in the Erk 
phosphorylation level (Figure 4.7A).  
 
 
Figure 4.7.  Mastl modulates MAPK 
activation in megakaryocytes and platelets. 
(A) Western blot analysis for phospho-Erk1/2, 
total Erk1/2, phospho-AKT and total AKT 
levels in extracts from primary bone marrow 
megakaryocytes (CD41+) from Mastl(+/+), 
Mastl(D/D) and Mastl(/) mice. (B) Platelet 
extracts isolated from platelet-rich plasma 
(PrP) from 12 week-old Mastl(+/+), Mastl(D/D) 
and Mastl(/) mice and analyzed for Erk1/2 
phosphorylation. (C) Blood platelet CD42 and 
CD41 expression from Mastl(+/+), Mastl(D/D) 
and Mastl(/) mice. 
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Figure 4.8.  Mastl modulates MAPK activation in the megakaryocytic cell line HEL. (A) Schematic 
representation of the protocol followed for Mastl knock-down in HEL cell line. (B) Western blot analysis for 
phospho-Erk1/2, and MASTL levels in extracts from HEL cells  transduced with lentiviruses expressing 
either a short hairpin against Mastl or full length Mastl fused to GFP (GFP-wt Mastl) and treted with TPO for 
the indicated times following the protocol in sheme A. (C) Immunoblotting of HEL cells stably expressing 
GFP-wt Mastl, GFP-E166D Mastl, or GFP-D156A (kinase dead mutant) upon TPO stimulation for the 
indicated times and cell cyle profiles by DAPI staining and FACS analysis. 
Importantly we observed a similar increase in the Erk phosphorylation status of resting blood 
platelets freshly isolated from Mastl(D/D) mice compared to control ones (Figure 4.7B). In 
addition platelets isolated from Mastl(D/D) mice showed a clear reduction in the CD42 
glycoprotein which is part of VWF receptor while CD41 was similarly expressed in both 
platelet groups (Figure 4.7C).  
PP2A is known to revert the phosphorylation of Erk in different cell types (Liu et al. 
2013; Sunahori et al. 2013) and Erk signaling is known to be critical in several functions in 
megakaryocytes such as maturation (Besancenot et al. 2010) and pro-platelet formation 
(Mazharian et al. 2009; Bluteau et al. 2014), as well as in platelet activation (Gushiken et al. 
2008; Pawlowski et al. 2002). This led us to form the hypothesis that Mastl either direct or 
indirect affects Erk activation pathway. The deregulated Erk activity might cause the lack of 
maturation in the Mastl() megakaryocytes where p-Erk levels found to be reduced, while 
in Mastl() megakaryocytes the enhanced Erk activitation could allow megakaryocytic 
maturation but lead to defects during the proplatelet formation. To test this hypothesis we 
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chose the human megakaryoblastic leukemia cell line (HEL) and analyzed the Erk activation 
pathway upon changes in Mastl expression 
As a general outline we serum starved the cells for 4 hours to eliminate any basal 
activation of the pathway and in absence of serun we stimulated the cells with the addition of 
100 ng/ml of recombinant TPO. The activation of the MAPK signaling pathway was 
evaluated in the indicated time points (Figure 4.8A). To analyze the role of Mastl in the Erk 
activation pathway we treated the HEL cell line with two independent short hairpin sequences 
against human Mastl sequence (shMastl No1, shMastl No2) and we found that in both cell 
groups treated with shMast presented reduced p-Erk levels. Impotantly we could appreciate 
that the major phosphorylation differences were observed at 30 and 40 min upon TPO 
stimulation while the peak activity at 10 min was not significantly different, indicating that 
Mastl absence affects the dephosphorylation rate of Erk1/2 rather than the upstream activation 
likely through direct inhibition of PP2A which is known to dephosphorylate Erk and hence 
avoid sustained activation of the pathway (Figure 4.8B). Accordingly we were able to restore 
Erk phosphorylation kinetics through the re-expresion of wild-type Mastl fused to GFP 
(Figure 4.8C). Interestingly Erk phosphorylation levels were overall increased upon Mastl 
overexpression compared to cells expressing only endogenous Mastl, likely because of 
enhanced PP2A inhibition. To further establish the relationship between Mastl activity and 
Erk activation we generated stable HEL cell lines expressing either wild-type E167D mutatnt 
or kinase-dead (KD) Mastl, fused to GFP. Consistently to the previous data, loss of Mastl 
activity (Mastl KD) led to reduced p-Erk levels while expression of Mastl bearing the 
thrombocytopenia mutation (E167D) presented sustained Erk phosphorylation, an additional 
evidence that the E167D mutant is a gain of function mutation that could lead to enhanced 
PP2A inhibition (Figure 4.8C). The differences in p-Erk levels obtained from different Mastl 
protein expression are not a consequence of cell cycle arrest in different cell cycle phases 
since the several stable cell lines presented similar cell cycle profiles and p-H3 levels (Figure 
4.8C). 
4.1.4. Effect of E166D mutation on platelet clearance 
Mastl E166D mutant platelets showed defects in the expression of CD42 glycoprotein 
although Mastl E166D mutant megakaryocytes presented only moderate defects in proplatelet 
formation. We therefore tested for additional defects in Mastl(D/D) platelets. To test this 
hypothesis we evaluated the in vivo platelet life span. For this purpose we stained the whole 
pool of circulating platelets and monitored the daily decay in stained platelets for up to 5 
days, indicative of their destruction and clearance by the spleen.  
Interestingly while Mastl(+/+) and Mastl(/) mice display similar platelet destruction 
rate, mice bearing either one or two MastlE166D alleles showed significantly enhanced decay 
of stained platelets  at day 2 and 3 suggesting decreased platelet life span in those mice 
(Figure 4.9A). 
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Figure 4.9. Determination of the in vivo platelet life span in Mastl(+/+), Mastl(D/D) Mastl(+/D) and 
Mastl(/) mice. (A) Mice between 8 and 12 weeks of age were injected with 600 g NHS-biotin to label 
platelets in vivo (Day 0). Results are percentage of fluorescently labeled platelets at the indicated days after 
injection as determined by flow cytometry. Values are mean ± SEM. n=5 mice per group (*, P < 0.05, **, P < 
0.01 Student’s t-test). (B) Scheme representing future experiments for analysinh any intrinsic defect in 
survival of Mastl(D/D) platelets. 
To define weather the reduced survival of platelets in Mastl(D/D) mice is a cell 
autonomous effect or not we plan to perform platelet adoptive transfers and study their in vivo 
life span in the recipient mice, since Mastl(D/D) mice express Mastl E166D ubiquitously and 
not only in megakaryocytes and platelets (Figure 4.9B). However the most plausible 
hypothesis is that because of the sustained Erk activation platelets released from Mastl(D/D) 
megakaryocytes present defects in survival. Against the non-cell autonomous hypothesis is 
the fact that human patients bearing the mutant Mastl allele and with thrombocytopenia 
syndrome did not show any improvement upon immunosuppressive treatment suggesting that 
at least in humans the reason behind thrombocytopenia development is not an autoimmune 
reaction. 
Altogether, these data suggest that, contrary to what was expected Mastl mutations in 
thrombocytopenia patients do not alter cell cycle progression or polyploidy but rather disrupt 
the normal regulation of MAPK pathways. In addition, these results describe a new cell cycle-
independent function for Mastl in the control of Erk phosphorylation. 
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4.2. Relevance of mitotic kinases during endomitotic progression 
In the following sections, we aim to further understand how endomitotic cycles are regulated 
through the specific genetic ablation of several cell cycle regulators in mature 
megakaryocytes (Figure 4.10).  
 
 
 
Figure 4.10. A general schematic representation of the possible involvement of several mitotic regulators 
during endomitosis. Their role in megakaryocytes will be investigated in the following sections by using 
tissue-specific genetic knockouts for the corresponding genes in the mouse. 
To this end, we will generate tissue-specific knockouts of  
 
a) proteins involved in mitotic progression (Aurora B, Plk1) 
b) regulators of the oscillations required for “cycling” (APC/C coactivators Cdc20 or 
Cdh1) 
c) kinases required for mitotic entry (Cdk1, Cdk2?) 
 
We will start in this section addressing the relevance of two kinases required for the proper 
segregation of chromosomes, Aurora B and Plk1. 
4.2.1. Aurkb is dispensable for megakaryocyte development and thrombopoiesis 
We first analyzed the relevance of Aurora B, a mitotic kinase with essential roles in the error-
correction mechanism that determines chromosome-microtubule attachments (Nezi & 
Musacchio 2009). Aurora B-null cells display a normal mitotic entry but prematurely exit 
from mitosis without being able to form bipolar spindles and in the absence of chromosome 
segregation (Fernández-Miranda et al. 2011;Trakala et al. 2013). Lack of Aurora B therefore 
results in tetraploidy followed by cell cycle arrest or death in cultured cells, and genetic 
ablation of kinase results in embryonic lethality in the mouse. 
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Figure 4.11. Aurkb is dispensable for megakaryopoiesis and platelet formation. (A) 
Hematoxylin/eosin-stained bone marrow sections and immunohistochemical staining of Von Wilebrand 
Factor (VWF) as a marker for megakaryocyte identification and maturation of 12 week-old mice. Pf4-Cre; 
Aurkb()  show normal megakaryocyte number, size and maturation by the analysis of VWF. (B) Blood 
platelet levels from 8-12 week old Pf4-Cre; Aurkb() and Pf4-Cre; Aurkb() mice. No changes were 
detected in blood platelet levels of Pf4-Cre; Aurkb() (P>0.05; t test) (C) Ploidy distribution inside the 
CD41 population in bone marrow by DAPI staining.  In Pf4-Cre; Aurkb() the ploidy distribution is similar 
compared to wild-type (p>0.05; t test). All graphs show mean with  SEM. Scale bars, 50 m and 20 m 
(insets). 
To understand the relevance of Aurora B in endomitosis and megakaryocyte 
development we made use of a conditional allele Aurkb(lox) previously generated in our lab 
(Fernández-Miranda et al. 2011) which upon Cre activation is excised leading to a null allele. 
Since complete ablation of Aurora B is embryonic lethal in mice, we crossed Aurkb(lox/lox) 
mice with Pf4-Cre transgenic mice. Pf4-Cre; Aurkb() [from now on Aurkb()] mice 
displayed normal survival and no overt defects during development. These mutant mice 
displayed fully matured megakaryocytes in the bone marrow as indicated by 
immunohistological staining for Von Wilebrand Factor (VWF; Figure 4.11A). Accordingly, 
we found no differences in blood platelet levels in Aurkb() mice (Figure 4.11B).  The 
absolute total number of megakaryocytes in mutant bone marrow was not altered as scored by 
CD41 staining (data not shown) and we found no significant differences in the ploidy 
distribution between Aurora B-null and control CD41+ cells (Figure 4.11C).  
We then isolated hematopoietic progenitors from fetal liver and we differentiated them 
towards megakaryocytes upon TPO addition (Figure 2). We did not observed either 
significant differences in the percentage of CD41+ cells along TPO stimulation for several 
days (Figure 4.12A), or in maturation levels of megakaryocytes as it is indicated by Giemsa 
staining at day 5 upon TPO stimulation (Figure 4.12B).  
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Figure 4.12. Aurora B null megakaryocytes can mature and shed platelets in vitro upon TPO 
stimulation. (A) CD41+ % of total alive cells analyzed by flow cytometry on days 2-5 after TPO 
stimulation of fetal liver cells extracted from E13.5 embryos. The cumulative percentages of CD41+ cells   
are similar in Aurkb(/) and Aurkb(+/+) (P>0.05; t test) . (B) Brightfield images of fetal liver derived 
megakaryocytes by day 5 and Giemsa staining where Aurora B-null cells can mature, as indicated by the 
light blue color, and platelet shedding occurs as it can be seen the proplatelet formation in right lower 
panel. Graphs show mean with  SEM. Scale bars, 50 m (C) Scheme representing the dispensable role 
of Aurora B in endomitosis and platelet formation. Statistics were performed by t test. 
Aurkb null megakaryocytes are fully proficient in platelet shedding (Figure 4.12B) 
indicating a complete maturation, terminal differentiation and full functionality of the cells. 
Overall these data suggest that Aurora B is dispensable for megakaryopoiesis and platelet 
formation in vivo (Figure 4.12C). 
4.2.2. Plk1 and Megakaryopoiesis 
Next we aimed to investigate the relevance of Polo-like kinase 1 (Plk1), an important kinase 
with essential roles not only in mitosis but throughout the whole cell cycle by regulating 
processes such as DNA damage response, mitotic entry, spindle formation, chromosome-
microtubule attachments, chromosomal cohesion, and cytokinesis. As a consequense of the 
many critical functions of Plk1, genetic ablation of this kinase results in embryonic lethality 
in the mouse (P. Wachowicz, G. de Cárcer and M. Malumbres, unpublished data). Plk1-null 
early embryos (E1.5) and MEFs displayed massive arrest in prometaphase-like stages with 
unaligned chromosomes in presence of mono- and multi-polar spindles. In some cases cells 
could progress through mitosis but exited mitosis without cytokinesis forming binucleated 
cells.  
The requirements for Plk1 in unconventional cell cycles have been barely studied. We 
therefore generated Pf4-Cre; Plk1() [from now on Plk1()] mice with specific ablation 
of Plk1 in megakaryocytes by crossing Plk1(lox/lox) mice (P. Wachowicz, G. de Cárcer and 
M. Malumbres, unpublished data) with Pf4-Cre transgenic mice. 
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Figure 4.13. Plk1 is essential for platelet formation (A) Hematoxylin/eosin-stained bone marrow sections 
and immunohistochemical staining of Von Wilebrand Factor (VWF) as a marker for megakaryocytic 
maturation of 12 week-old mice. Plk1(/) mice  show normal megakaryocyte number, size and maturation 
by the analysis of VWF. (B) Blood platelet levels from 8-12 week old Pf4-Cre; Plk1(/)  and Pf4-Cre; 
Plk1(/) mice. No changes were detected in blood platelet levels of Plk1(/) (P<0.05; t test) (C) Ploidy 
distribution inside the CD41 population in bone marrow by DAPI staining representative of three 
experiments. All graphs show mean with  SEM. Scale bars, 50 m and 20 m (insets).  
Plk1() mice displayed normal development and survival being born at the expected 
frequency. These mutant mice displayed thrombocytopenia with average platelet count 284 ± 
75 compared to 864 ± 40 (mean ± SEM) in Plk1(lox/lox) littermates (Figure 4.13A,B). 
Surprisingly, by immunohistological staining for VWF in bone marrow sections we observed 
mature megakaryocytes although these megakaryocytes presented hypolobulated nuclei. In 
addition apart from the mature megakaryocytes we detected megakaryocytes smaller in size 
and with lower VWF signal likely arrested in endomitosis as is it indicated by the presence of 
condensed chromatin in H/E staining and by pH3 positive mitotic signal (Figure 4.13A). In 
agreement with the presence of small mitotic and mature megakaryocytes evaluating the 
ploidy distribution of Plk1() mice we observed that the 16C and 32C populations were 
almost identical to the control ones whereas low ploidy (4C and 8C) megakaryocytes were 
more abundant likely as a consequence of the mitotic arrest (Figure 4.13C). Overall these data 
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show that Plk1 is essential for platelet formation and lack of this kinase may result in partial 
defects in megakaryocyte polyploidization. Yet, the molecular reasons for these defects have 
not been determined in this work and remain to be explored. 
4.3. Regulation of endomitosis by the APC/C 
4.3.1. APC/C-Cdh1 is essential for endoreplication but not for endomitosis 
APC/C-Cdh1 is responsible for maintaining low levels of mitotic cyclins in interphase and its 
activity is critical to prevent mitosis and drive endoreduplication in Drosophila (Sigrist & 
Lehner 1997) and mammalian trophoblast giant cells (Garcia-Higuera et al. 2008). Its role in 
endomitosis, however, has not been established.  
We therefore generated Pf4-Cre; Cdh1() [from now on Cdh1()] mice with 
specific ablation of Cdh1 in megakaryocytes by crossing Cdh1(lox/lox) mice (Garcia-Higuera 
et al. 2008) with Pf4-Cre transgenic mice.  Cdh1() mice displayed normal development 
and survival being born at the expected frequency and no differences were observed in mature 
megakaryocytes after staining with VWF (Figure 4.14A). Mature megakaryocytes displayed 
increased levels of phosphorylation of H2AX (H2AX) in agreement with the generation of 
replicative stress in the absence of this molecule (Eguren et al. 2013). This phenotype is likely 
a consequence of increased Cdk activity during replication entry and progression due to 
increased levels of cyclins in the absence of Cdh1 (Eguren et al. 2008). Lack of Cdh1 also 
resulted in a slight decrease in the levels of highly polyploid (16C or 32C) megakaryocytes 
(Figure 4.14B), although these differences did not result either in a significant defect in the 
number of peripheral blood platelets (Figure 4.14C) or in serum TPO level (Figure 4.14D),  
thus suggesting that Cdh1 ablation does not impair megakaryocyte function  
4.3.2. APC/C-Cdc20 is essential during endomitosis 
We next explored the relevance of the other APC/C coactivator by specifically ablating 
Cdc20 in megakaryocytes. Cdc20 is known to be essential for exiting from the mitotic cycle 
since its absence prevents degradation of securin and cyclin B (Manchado, et al. 2010). Cdc20 
ablation in cells results in metaphase arrest due to the high levels of cyclin B1 that prevent 
Cdk1 inactivation and anaphase onset (Manchado et al., 2010). Specific genetic ablation of 
Cdc20 in megakaryocytes resulted in a dramatic phenotype characterized by severe 
thrombocytopenia with average platelet count of 108 ± 13 x109/L platelets (mean ± SEM) in 
Cdc20() mutant mice compared to 782 ± 37 x109/L in Cdc20(lox/lox) littermates (Figure 
4.15A).  
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Figure 4.14. Cdh1 is dispensable for megakaryocytic maturation and platelet production. (A) 
Hematoxylin/eosin-stained bone marrow sections and immunohistochemical staining for Von Wilebrand 
Factor (VWF) as a marker for megakaryocyte identification and maturation, pH3 as G2/M marker and 
H2AX in 12 week-old mice. Cdh1(/) mice show normal megakaryocyte number, size and maturation by 
the analysis of VWF. (B) Blood platelet levels from 8-12 week old Cdh1(lox/lox) and Cdh1(/) mice. No 
changes were detected in blood platelet levels of Cdh1(/) (P>0.05; t test) (C) Serum TPO from mice 
between 8-14 week-old ) (P>0.05; t test). n=5 per group. (D) Ploidy distribution inside the CD41 population 
in bone marrow by DAPI staining, representative of three experiments. All graphs show mean with  SEM. 
Scale bars, 50 m. 
In agreement with the presence of thrombocytopenia, we found in the bone marrow of 
Cdc20() mutant mice a complete lack of mature megakaryocytes although with a robust 
increase in the total number of VWF positive cells (Figure 4.15B,C). In Cdc20() mutant 
mice, the VWF positive cells were significantly smaller indicating lack of maturation (Figure 
4.15B,D). These low-size megakaryocytes displayed abundant mitotic figures in the presence 
of phosphorylated histone H3, suggesting mitotic arrest in the absence of Cdc20 (Figure 
4.15B, F). In addition, evaluating the ploidy distribution of megakaryocytes in Cdc20() 
mutant mice we observed that the 16C and 32C populations were almost absent whereas low 
ploidy (4C and 8C) megakaryocytes were more abundant likely as a consequence of the 
mitotic arrest (Figure 4.15E,F). 
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Figure 4.15. Cdc20 is essential for megakaryocytic polyploidization and platelet production. (A) 
Blood platelet levels from Cdc20(lox/lox) n=23 and Cdc20(/) mice n=30. (P<0.0001) (B) 
Hematoxylin/eosin-stained bone marrow sections and immunohistochemical staining for Von Wilebrand 
Factor (VWF) and pH3. Scale bars, 50 M. (C) Percentage of CD41+ cells in bone marrow by FACS 
analysis. (D) Morphometric analysis of VWF+ cells in bone marrow sections. Total cells from N=3 per group 
animals. Each dot represents an individual cell (P<0.0001) (E) Ploidy distribution inside the CD41 
population in bone marrow by DAPI staining, representative of three experiments. (F) Percentage of pH3+ 
cells in bone marrow sections by high power field analysis (hpf) 10 hpf of 3 animals per grouped were 
analyzed (P<0.0001).  All graphs show mean with  SEM and all experiments were performed in 8-14 
weeks-old animals. Statistics were performed by t test. 
As it is well established in other thrombocytopenia models, lack of peripheral platelets leads 
to higher levels of free TPO (TPO levels are tightly controlled by direct binding to the 
circulating platelets) which subsequently stimulates not only higher commitment of 
progenitors to the megakaryocytic lineage but also the expansion of uncommitted progenitors 
(Ng et al. 2014). (In Cdc20() mutant mice since there is almost a complete lack of 
circulating platelets we could expect such an increase in early megakaryocytes and 
progenitors in general. Indeed we observed an increase in megakaryocytic progenitors not 
only in bone marrow but also in the spleen (Figure 4.16A). In addition we analyzed the levels 
of hematopoietic progenitors in the bone marrow and we observed a significant increase in all 
subtypes of hematopoietic progenitors (including hematopoietic stem cells and common 
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myeloid progenitors) except for the common lymphoid progenitors where TPO is known to 
have no effect (Figure 4.16B). In agreement with the notion that thrombocytopenia is the 
cause of the enhanced mekagaryocytic progenitors in bone marrow, we found no differences 
in the number of megakaryocytic progenitors in fetal livers from 12.5 p.c Cdc20() mutant 
embryos compared to Cdc20(lox/lox) littermates [at this developmental stage TPO is supplied 
mainly by the mother (Petit-Cocault et al. 2007) (Figure 4.16C). When we cultured fetal liver 
progenitors in presence of TPO for three days, we observed a similar phenotype in the Cdc20 
null megakaryocytes since were smaller than control megakaryocytes, and presented 
condensed DNA and positive signal for mitotic regulators such as Aurora B suggesting 
mitotic arrest in vitro (Figure 4.16D). 
 
 
Figure 4.16. High levels of hematopoietic progenitors as a consequense of severe 
thrombocytopenia in Cdc20(/) mice. (A) Hematoxylin/eosin-stained spleen marrow sections and 
immunohistochemical staining for Von Wilebrand Factor (VWF) Scale bars, 50 m. (B) Percentage of 
distinct subgroups of hematopoietic progenitors from bone marrow by FACS analysis. HSCs (Hematopoetic 
stem cells), CLPs (common lympoid progenitors), CMPs (Common myeloid progenitors), MEPs 
(megakaryocyte-erythrocyte progenitors), GMPs (granylocyte-macrophage progenitors). n=5 per group (C) 
FACS analysis of total fetal liver from 12.5 embryos (FL) and bone marrow of 8 weeks-old mice (BM) for 
Lin-CD41+ population. [N=3; (P<0.0001)] (D) Total fetal liver cells from 12.5 Cdc20(lox/lox) and Cdc20(/) 
embryos from the same pregnant mother stimulatated with TPO for 3 days. Brightfield and Giemsa staining 
of cytospun cells and Immunofluorescence (IF) for Aurora B in red and DAPIi in blue Scale bars, 50 m. All 
graphs show mean with  SEM and all experiments were performed in 8-12 weeks-old animals. Statistics 
were performed by t-test. 
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To further understand the cellular consequences of Cdc20 ablation we differentiated 
bone marrow progenitors to megakaryocytes with thrombopoietin from Cdc20() and 
Cdc20(lox/lox) mice and monitored the polyploidization events by videomiscroscopy. For 
this purpose we transduced bone marrow progenitors with lentiviral vectors expressing 
histone H2B fused to the green fluorescent protein (H2B-GFP). Also, to identify those cells 
that underwent recombination upon Cre expression under the Pf4 promoter, we crossed 
Cdc20()mice with transgenic mice expressing a lox-Stop-lox cassette upstream the 
Katushka fluorescence protein (Diéguez-Hurtado et al. 2011). As depicted in Figure 4.17A, 
control megakaryocytes underwent typical endomitotic cycles in which cells displayed 
condensed DNA for about 1-2 h and exited mitosis in the absence of chromosome segregation 
(Papadantonakis et al. 2008). However, most Cdc20() megakaryocytes displayed a normal 
entry into endomitosis and arrested with condensed chromosomes during 9-20 h until cell 
death (Figure 4.17A, B). Given the high number of mitotic figures in the bone marrow and the 
dramatic deficiency in platelets, these data are indicative of the essential relevance of 
endomitosis as the major endocycle for megakaryocyte maturation in vivo (Figure 4.17C). 
 
Figure 4.17. Cdc20 null megakaryocytes arrest in endomitosis. (A) Time-lapse microscopy of bone 
marrow derived megakaryocytes stably expressing histone H2B-GFP (green). The red color in Cdc20(/) 
megakaryocytes corresponds to katushka fluorescent protein which is expressed upon the Cre mediated 
lox-Stop-lox cassette excision (LSL-KFP). (B) Duration of mitosis (DOM) in minutes estimated by the 
analysis of individual cells by time-lapse microscopy (n=12 per group). In Cdc20(/) megakaryocytes the 
DOM is considered for the time that cells present condensed chromatin till the time of cell death. (C) 
Scheme representing the essential role of Cdc20 for exit from endomitosis in megakaryocytes and platelet 
formation. Statistics were performed by t-test (***, p<0.001). 
Results 
 
72 
 
4.3. Regulation of entry into endomitosis 
4.3.1. Cdk1 is essential for endomitosis but dispensable for megakaryopoiesis 
By definition, endomitotic cells do enter into mitosis and exit without segregation, whereas 
during endoreduplication cells completely skip mitosis. The later has been associated to the 
lack of Cdk1 activity (Zielke et al., 2013), an essential kinase required for mitotic entry 
(Santamaria et al., 2007). We therefore tested the consequences of eliminating Cdk1 activity 
during endomitosis by crossing Cdk1(lox/lox) mice with Pf4-Cre transgenic animals. 
Surprisingly, the resulting Cdk1() mice did not display major defects in megakaryocyte 
number, morphology or VWF staining in adult mice (Figure 4.18A). Similarly, although the 
ratio of highly polyploid (16C and 32C) megakaryocytes was slightly reduced, no major 
defects were observed in the ploidy of these mutant mice (Figure 4.18B) and the number of 
platelets in peripheral blood was similar to that of control littermates (Figure 4.18C).  
 
 
Figure 4.18. Cdk1 ablation does not lead to defects in megakaryocyte polyploidization and platelet 
defects in vivo. (A) Hematoxylin/eosin-stained bone marrow sections and immunohistochemical staining 
for Von Wilebrand Factor (VWF) and pH3. Morphometric analysis of VWF+ cells in bone marrow sections. 
Total cells from N=3 per group animals. Each dot represents an individual cell (P>0.05) (B) Ploidy 
distribution inside the CD41 population in bone marrow by DAPI staining, representative of three 
experiments. (C) Blood platelet levels from Cdk1(lox/lox) and Cdk1(/) mice. [n=19; P>0.05; t test]. (D) 
Western blot analysis for Cdk1 in freshly isolated megakaryocytes (CD41+ cells) from bone marrow. To 
determine ploidy megakaryocytes were stained with Hoechst and CD41+ cells were shorted according the 
DNA content into two populations (2C-4C) and (>4C). All graphs show mean with  SEM. Scale bars, 50 
m. 
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Figure 4.19. Bone marrow derived Cdk1(/) megakaryocytes can polyploidize In vitro. (A) Western 
blot analysis for Cdk1 in bone marrow derived megakaryocytes for DNA content greater that 4C upon TPO 
stimulation for 3 days. Vinculin is used as a loading control. (B) CD41+ cell polyploidization analyzed by flow 
cytometry stained with DAPI at days 2 and 4 after TPO stimulation. (C) Giemsa staining of Cdk1(lox/lox), 
Cdk1(/), and Cdc20(/) megakaryocytes upon 4days of TPO stimulation. Scale bars, 20 m. 
Whereas Aurora B, Cdh1 or Cdc20 protein levels are controlled by cell cycle-
regulated ubiquitin-dependent proteolysis Cdk1 is more stable, raising the question whether 
the depletion of this protein was not efficient in this system. However, we observed a 
significant reduction in Cdk1 protein levels in mature megakaryocytes isolated from the bone 
marrow of 12-week-old Cdk1() mice (Figure 4.18D). Similar depletion in Cdk1 protein 
levels was obtained after incubation of bone marrow progenitors with TPO in vitro (Figure 
4.19A), suggesting that the lack of an obvious phenotype in platelet production was not due to 
inefficient ablation of Cdk1. Cdk1() megakaryocytes accumulated normal levels of ploidy 
(Figure 4.19B), and displayed a morphology indistinguishable from wild-type cells, whereas, 
as a control, Cdc20() megakaryocytes presented smaller nuclear size and condensed DNA 
(Figure 4.19C). 
4.3.2. Cdk1-deficient megakaryocytes undergo endoreplication 
We then monitored polyplodization in Cdk1() megakaryocytes by time-lapse microscopy. 
Bone marrow progenitors were transduced with lentiviral vectors expressing lamin-CFP, to 
stain nuclear envelope, and H2B-GFP to label chromatin. In addition, we used a vector 
expressing geminin-mCherry, a DNA replication regulator induced in S-phase and degraded 
in an APC/C-dependent manner during mitotic or endomitotic exit (Sakaue-Sawano et al., 
2013; Sakaue-Sawano et al., 2008). Using these markers and quantification of nuclear and 
cellular volumes, endocycles can be readily monitored in wild-type megakaryocytes. To 
calculate the nuclear volume we identify the nuclear area based on histone-GFP signal and 
calculate the radius by using the equation: 
 
A  4r2 where A stands for area and r for radius. 
Then we calculate the volume by using the equation: 
 
V  4
3
r 3   where V represents volume 
and r radius (Figure 4.20).  
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Figure 4.20. Time-lapse microscopy for endomitotic polyploidization in vitro. Time-lapse microscopy 
of bone marrow derived megakaryocytes stably expressing green for histone-GFP (H2B-GFP), blue for 
lamin-CFP and red for geminin-mcherry. (A) Representative pictures of an individual cell depict the G1-S 
transition during an endomitoc cell cyle. As time T=0 is considered the exit from endomitosis characterized 
by degradation of geminin (red), decondensation of chromatin (green) and nuclear envelope reformation 
(blue). During G1-phase cells are negative for geminin and start to express it upon G1-S transition. During 
s-phase the increase in nuclear volume can be appreciated. (B) Representative pictures of an individual cell 
during endomitosis. Endomitosis is characterized by chromatin condensation, absence of nuclear envelope 
that has as a consequence the pancellular distribution of geminin, which in other phases is exlusively 
nuclear. In late stages of endomitosis geminin is degraded and upon endomitotic exit nuclear envelope 
reforms and chromotin decondensates. (C) Graphs showing the relative units of geminin-mcherry mean 
fluorescent intensity, H2B-GFP mean fluorescent intensity, and nuclear and cellular volume during the 
endomitotic cell cycle. The purple frame depicts endomitosis (M) 
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Accordingly S-phase can be estimated from the increase in nuclear volume and histone-
GFP intensity that take place during the gemininhigh phase. Mitosis is indicated by 
condensation of chromosomes; and pan-cellular distribution of lamin or geminin as a 
consequence of the lack of nuclear envelop. Finally, mitotic exit is indicated by degradation 
of geminin, reformation of the nuclear membrane and decondensation of DNA (Figure 20). 
Wild-type megakaryocytes were recorded for several days and the behavior of 
individual cells was analyzed. Most wild-type megakaryocytes were characterized by mitosis 
in the absence of karyokinesis and cytokinesis (endomitosis). Degradation of geminin 
(gemininlow) was observed mainly during endomitotic exit as expected and in most cases was 
followed by re-expression of geminin (gemininhigh) after a gap phase indicating the 
reasumption of a new endomitotic cell cycle (condensed chromosomes and pan-cellular 
geminin signal (Figure 4. 20A,B) By cuantifing the nuclear volume throughout the whole 
video we were able to estimate the nuclear volume increase between two geminhigh phases. As 
mentioned previously we detected an approximate ~2 fold increase (Figure 4. 20C) 
suggesting DNA replication in each of these endocycles. Cell volumes also increased during 
this process although without correlating with any particular phase.  
Then by using the same approach we analyzed Cdk1() megakaryocytes recorded 
simultaneously with wild-type megakaryocytes. In most Cdk1() megakaryocytes we 
observed as well geminin oscillations although geminin degradation occured in the absence of 
endomitosis (Figure 4.21A-B,D-E). In these cells, geminin did not show pan-cellular signal in 
agreement with the maintenance of the nuclear envelope and the lack of chromosome 
condensation. Geminin re-expression in many cases was come after geminin degradation and 
a subsequent gap phase, indicating a new cell cycle. Importantly nuclear volume increased 
about 2-fold in each of these endocycles when compared to normal endomitotic cells (Figure 
4.21C,F) suggesting the presence of endoreplication throughout the gemininhigh phase. The 
increase in ploidy was similar in endomitotic and endoreplicative cells indicating that 
megakaryocytes are able to polyploidize using endoreplication as an alternative route to 
endomitosis in the absence of Cdk1. In consistence with our previous results we detected as 
well a small proportion of small megakaryocytes (~12%) that underwent endomitosis likely 
because of low expression of Cre and therefore remaining Cdk1.  
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Figure 4.21. Endomitotic and endoreplicative endocycles in Cdk1(lox/lox) and Cdk1(/) 
megakaryocytes respectively. (A) Graph representing the cell fate of individual cells recorded by life cell 
imaging of Cdk1(lox/lox) bone marrow derived megakaryocytes for approximately 5 days . Cells express 
stably H2B-GFP and Geminin-mcherry. The red frame stands for S-G2 phases during which geminin is 
expressed (gemininhigh). The green frame represents G1 during which geminin is degraded (gemininlow). 
Endomitosis is illustrated as a black box surrounded by a purple frame. (B) Representative pictures of an 
individual cell during endomitotic endocycling. (C) Graphs showing the temporal profiles of geminin 
fluorescent intensity, nuclear volume and cell volume.  Each line represents an individual cell and purple 
frame depicts endomitosis. Black arrows highlight the two-fold increase of nuclear and cellular volume 
between two gemininhigh phases. (D) Similar to (A) graph representing the cell fate of individual cells 
recorded by life cell imaging of Cdk1(/) bone marrow derived megakaryocytes for approximately 5 days 
in absence of endomitosis. Red circle indicates cell death (E) Similar to B representative pictures of an 
individual cell during the endoreplicative endocycling of Cdk1(/) megakaryocytes. (F) Similar to (C) 
graphs showing the temporal profiles of geminin fluorescent intensity, nuclear volume and cell volume in 
endoreplicative megakaryocytes. Each line represents an individual cell and purple frame depicts 
endomitosis. Black arrows highlight the two-fold increase of nuclear and cellular volume between two 
gemininhigh phases 
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Figure 22. Cdk1(/); Cdk2(/) megakaryocytes polyploidize through rereplication. (A) 
Hematoxylin/eosin-stained bone marrow sections and immunohistochemical staining for Von Wilebrand 
Factor (VWF), pH3 and 2HAX. Scale bars, 50 m (insets 20 m). (B) Blood platelet levels from 
Cdk2(/), Cdk1(/);Cdk2(+/) and Cdk1(/);Cdk2(/) mice. [n=19; P>0.05; t-test] (C) Ploidy 
distribution inside the CD41 population in bone marrow by DAPI staining, representative of three 
experiments. Discrete peaks corresponding to different DNA content are indicated by 2C, 4C, 4C, 16C and 
32C.  Bracket indicates the diffuse pattern of high ploidy (>8C) megakaryocytes.  
4.4. Cdk2 and Cdk1 prevent re-replication in megakaryocytes 
4.4.1. Cdk2 prevents re-replication in the absence of Cdk1 
Cdk1 is known to be essential for entry into mitosis in all cells analyzed so far (Adhikari et 
al., 2012; Diril et al., 2012; Satyanarayana et al., 2008)(unpublished data from M. Barbacid’s 
lab), and the presence of a few cells undergoing mitosis in the absence of Cdk1 (Figure 
4.21D) likely suggested incomplete removal of endogenous Cdk1. However, since Cdk2 can 
also bind mitotic cyclins, we tested whether Cdk2 could compensate for Cdk1 activity in 
megakaryocytes by using a Cdk2-null allele (Ortega et al., 2003). Lack of Cdk2 does not 
results in obvious defects in the mouse and Cdk2() mice displayed normal numbers and 
morphology of megakaryocytes as well as normal number of platelets (Figure 4.22A,B) 
Similarly, lack of Cdk2 did not dramatically altered megakaryocyte morphology or platelet 
numbers in a Cdk1() background (Figure 4.22A,B), although Cdk1(); Cdk2() 
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megakaryocytes frequently displayed phosphorylation of H2AX (H2AX signal), suggesting 
replicative stress in the absence of these two Cdks (Figure 4.22A,C). These data correlated 
with a diffuse pattern of high ploidy megakaryocytes in the absence of the expected discrete 
8C, 16C or 32C populations suggesting that the genome in Cdk1(); Cdk2() 
megakaryocytes was not uniformly and integrally duplicated (Figure 4.22D). 
We next evaluated the consequences of Cdk2 ablation in Cdk1-null megakaryocytes by 
time-lapse microscopy with lamin-CFP for nuclear envelope, H2B-GFP for chromatin and 
geminin-mCherry for monitoring cell cycling. Cdk1(); Cdk2() megakaryocytes 
presented similar endocycles characterized by gemininlow and gemininhigh phases without 
evidences for mitosis in most cases (Figure 4.23A) The small percentange of endomitosis we 
detected (around of 15-18%) usually occurs in small size megakaryocytes and likely is due to 
inefficient Cre activity. Interestingly, gemininhigh phases were significantly longer when 
compared to wild-type or Cdk1() cells (Figure 4.23B) and the increase in nuclear volume 
in a single gemininhigh phase was of 5-fold compared to 2-fold in wild-type cells or Cdk1-
deficient megakaryocytes. 
 
Figure 4.23. Cdk1(/); 
Cdk2() megakaryocytes 
polyploidize in the absence of 
endomitosis or endo-replication. 
(A) Graph representing the cell fate 
of individual cells recorded by life 
cell imaging of Cdk1(/);Cdk2(-/-) 
bone marrow derived 
megakaryocytes for approximately 
5 days. Cells express stably H2B-
GFP, lamin CFP and geminin-
mcherry. The red frame stands for 
S-G2 phases during which geminin 
is expressed (gemininhigh). The 
green frame represents G1 during 
which geminin is degraded 
(gemininlow). Endomitosis is 
illustrated as a black box 
surrounded by a purple frame. (B) 
Representative pictures of 
Cdk1(/); Cdk2() 
megakaryocytes. Graphs shows 
the temporal profiles of geminin 
fluorescence intensity and nuclear 
volume. 
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Figure 4.24. Cdk1 and Cdk2 ablation rescues megakaryocyte defects and platelet levels in the 
absence of Cdc20. (A) Hematoxylin/eosin-stained bone marrow sections and immunohistochemical 
staining for Von Wilebrand Factor (VWF), pH3 and 2HAX for the indicated genotypes. Scale bars, 50 m 
(B) Graph shows the distribution of megakaryocyte size estimated by VWF positive signal. Each dot 
represents an individual cell. Total cells analyzed per group (400) come from 3 individual animals (N=3). (C) 
Ploidy distribution inside the CD41 population in bone marrow by DAPI staining, representative of three 
experiments. Discrete peaks corresponding to different DNA content are indicated by 16C and 32C. (D) 
Mitotic index inmegakaryocytes from mice with the indicated genotypes. At least 300 cells from three 
different animals per genotype were scored. Scale bars, 20 m. (E) Blood platelet levels from 
Cdc20(+/+);Cdk1(+/+);Cdk2(+/+); n=25, Cdc20(/);Cdk1(+/+);Cdk2(+/+); n=30, 
Cdc20(/);Cdk1(/);Cdk2(+/+) n=22, Cdc20(/);Cdk1(/);Cdk2(+/); n=9 and 
Cdc20(/);Cdk1(/);Cdk2(); n=7. Each dot represents an individual animal. All graphs show mean 
with  SEM and all experiments were performed in 8-14 weeks-old animals. Statistics were performed by t-
test (***, p<0.001). Graph shows percentage of endomitotic megakaryocytes in bone marrow sections by 
high power field analysis (hpf) 10 hpf of 3 animals per group were analyzed (P<0.0001) 
4.4.2. Cdk1 and Cdk2 ablation rescues platelet defects in the absence of Cdc20 
Since inactivation of Cdk1 and Cdk2 may induce a switch in endocycles from endomitosis to 
endoreduplication or possibly re-replication, we hypothesized that lack of Cdks could rescue 
the mitotic-specific defect observed in Cdc20-null megakaryoyctes. We therefore generated 
Pf4-Cre; Cdc20(); Cdk1() or Pf4-Cre; Cdc20(); Cdk1(); Cdk2() mutant 
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mice. As it is shown in Figure 4.24, whereas genetic ablation of Cdc20 was characterized by 
the presence of small megakaryocytes frequently arrested in mitosis, ablation of Cdk1 
allowed the accumulation of big megakaryocytes that were strongly positive for VWF, 
suggesting proper maturation (Figure 4.24A,B) and ploidy (Figure 4.24C). This rescue in 
Cdc20(); Cdk1() megakaryocytes correlates with the reduction of mitotic cells  
compared to Cdc20() megakaryocytes (Figure 4.24D). In addition, although Cdc20(); 
Cdk1() mice also developed thrombocytopenia, the mean number of platelets increased 
from 108 ± 13 x109 platelets/L in Cdc20(); Cdk1(lox/lox) animals to 376 ± 18 x109 
platelets/L in Cdc20(); Cdk1() double mutant mice, suggesting a significant rescue 
(Figure 4.24E).  
Interestingly, concomitant ablation of one or two alleles of Cdk2 further improve this 
rescue as Cdc20(); Cdk1(); Cdk2() triple mutants displayed large megakaryocytes 
with strong signal for VWF (Figure 4.24A,B) ploidy (Figure 4.24C) and platelet number 
(Figure 4.24D). Cdc20(); Cdk1(); Cdk2(+/) mice displayed 490 ± 23 x109 platelets/L 
and Cdc20(); Cdk1(); Cdk2() displayed 598 ± 42 x109 platelets/L in peripheral 
blood. Interestingly Cdc20(); Cdk1(); Cdk2() megakarycocytes frequently 
presented  phosphorylation of H2AX (H2AX signal), suggesting replicative stress in the 
absence of these two Cdks (Figure 4.24A).  
4.4.3. Re-replication in the absence of Cdk1 and Cdk2 
To verify the type of polyploidization that Cdc20(); Cdk1() and Cdc20(); 
Cdk1(); Cdk2(/) megakaryocytes underwent and led to the Cdc20 null phenotype rescue 
we monitored the endocycling by time lapse video microscopy using the lamin-CFP, H2B-
GFP and geminin-mCherry syctem (Figure 4.25). By recording for several days and analyzing 
individual cells we observed megakaryocytes that showed geminin oscillations although 
geminin degradation occured in the absence of endomitosis indicating endoreplicative 
endocycling (Figure 4.25A). In agreement with the partial rescue of platelet levels in vivo 
about half of Cdc20(); Cdk1() megakaryocytes entered and arrested in mitosis till cell 
death.  
The fact that Cdk1 levels are quite stable throughout the cell cycle whereas Cdc20 
protein levels are regulated through the proteolytic pathway might result in the earlier 
exhaustion of Cdc20 protein upon Cre-mediated excision compared to the Cdk1, thus 
explaining the high percentage of endomitotic arrest in Cdc20(); Cdk1() 
megakaryocytes. Similarly Cdc20(); Cdk1(); Cdk2() megakaryocytes displayed 
alternative endocycling with gemining oscillations in absence of endomitosis although 
gemininhigh phases were considerably longer suggesting rereplicative endocycling (Figure 
4.25B).  
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Figure 4.25. Re-replication in alternative endocycling megakaryocytes. (A) Graph representing the cell 
fate of individual cells recorded by life cell imaging of Cdc20 (); Cdk1 () bone marrow derived 
megakaryocytes for approximately 5 days. Cells express stably H2B-GFP, lamin CFP and geminin-mcherry. 
The red frame stands for S-G2 phases during which geminin is expressed (gemininhigh). The green frame 
represents G1 during which geminin is degraded (gemininlow). Endomitosis is illustrated as a black box 
surrounded by a purple frame. Red circle depicts cell death. (B) Similar as in A for Cdc20(); Cdk1(); 
Cdk2() bone marrow derived megakaryocytes. (C) The percentage of re-replicated DNA tracks due to 
origin refiring within a single cell cycle. Representative pictures of two independent experiments of DNA 
fiber stretch assay in bone marrow derived megakaryocytes on day 4 upon TPO stimulation. For each 
sample at least 500 measurements were performed.  Data represent mean ± SEM; Student’s t-test (*, 
p<0.05; **, p<0.01; ***, p<0.001). 
Importantly, by employing the DNA fiber assay, we were able to evaluate the occurrence of 
multiple origin firing within a single cell cycle. While wild-type endomitotic as well as 
endoreplicative Cdk1() and Cdc20(); Cdk1() megakaryocytes displayed between 3-
4% of origin re-firing within a single cell cycle Cdc20(); Cdk1(); Cdk2() 
megakaryocytes presented 18% of origin re-firing; i.e. almost a 6-fold induction compared to 
wild-type cells, thus confirming re-replication in these cells. Both Cdc20(); Cdk1() 
and Cdc20(); Cdk1(); Cdk2() megakaryocytes were able to polyploidize bypassing 
the mitotic arrest induced by Cdc20 depletion, a feature that may explain the rescue in platelet 
levels in vivo.  
As indicated above, quantification of mitotic index in these models actually suggests 
that lack of Cdk1 or Cdk1 and Cdk2 prevents the mitotic arrest observed in Cdc20-deficient 
megakaryocytes (Figure 4.24D). Whereas more than 80% of megakaryocytes were arrested in 
mitosis in Cdc20-null bone marrows, these numbers are dramatically reduced in Cdc20-
deficient megakaryocytes that also lacked Cdk1 or Cdk1 and Cdk2. 
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Figure 4.26. Megakaryocyte nuclear shape during polyploidization. Images on the left show 
representative Hematoxylin/eosin-stained bone marrow sections showing the possible morphologies of 
megakaryocytes with complex poli-lobulated nuclei or reduced number of lobules. The histogram shows the 
relative presence of the different nuclear morphologies in megakaryocytes from mice with the indicated 
genotypes. White box indicates highly lobulated megakaryocytes, light grey trilobulated megakarycocytes, 
dark grey bilobulated cells and black box indicates monolobulated megakaryocytes. A total of 300 cells from 
three different mice were analyzed per genotype. Scale bars, 20 m. 
 
Importantly the nuclear shape of megakarcyocytes in these complex genotypes was 
hypolobulated (mainly mono- and bi-lobulated) when comparing to the lighly complex 
nuclear shapes found in control mice (Figure 4.26). Since endomitosis frequently results in 
polylobulated nuclei as a consequence of the abortive mitosis during the later stages of 
anaphase, these results suggest polyploidization in absence of endomitosis in vivo in doble or 
triple mutant mice. 
4.4.4. Endomitosis, endoreplication and re-replication can lead to functional 
megakaryocytes 
In the previous sections, we have shown that megakaryocytes can polyploidize through 
alternative endocycles other than endomitosis. In addition, the in vivo blood platelet numbers 
from several mouse models such as Cdk1(), Cdk1(); Cdk2(), Cdc20(); 
Cdk1() and Cdc20(); Cdk1(); Cdk2() indicate that these alternative endocycles 
can produce functional megakaryocytes which can form proplatelets and eventually realease 
platelets into the blood stream. To further analyze the ability of these cells for platelet 
shedding we performed assays where we scored the percentage of proplatelet bearing cells in 
mature, terminally differentiated bone marrow derived megakaryocytes as well the 
complexity of bifurcation of these proplatelets by -tubulin staining (Figure 4.27). 
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Figure 4.27. Alternative endocycles can lead to functional, platelet shedding megakaryocytes. In 
vitro bone marrow derived megakaryocytes analyzed at day 5 upon TPO stimulation. The percentage of 
PPT-forming megakaryocytes (left histogram)  was estimated by counting cells exhibiting 1 or more 
cytoplasmic protrusions with areas of platelet swellings as it is indicated by black arrows. 300-400 cells 
were analyzed per group. Right histogram represents the analysis of branching area of PPT-forming 
megakaryocytes after citospin and staining with anti–α-tubulin Ab (green) and DAPI (blue). The number of 
bifurcation was counted for each PPT-forming MK in a total of 20-50 megakaryocytes per group. Data 
represent mean ± SEM; Student’s t-test (*, p<0.05; **, p<0.01; ***, p<0.001). 
As expected at day 5 of differentiation wild-type endomitotic megakaryocytes 
presented 24 ± 2% (mean ± SEM) of proplatelet bearing cells with high level of bifurcation 
whereas in Cdc20() megakaryocytes only the 0.9 ± 0.5% of cells formed proplatetes 
(Figure 4.27). Cdk1() endoreplicative megakaryocytes resulted in a slight but not 
significant decrease in the percentage of proplatelet bearing cells scoring a 21 ± 2%. 
Accordingly concomitant ablation of Cdc20 and Cdk1 lead to a significant rescue of 
proplatelet formation scoring 7 ± 0.4%. In addition, further ablation of Cdk2 led to an even 
higher rescue in proplatelet formation with a 16 ± 3.5%.  
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Overall, these data show that alternatively polyploidized megakaryocytes can also 
form platelets, although these alternative endocycles may be less efficient compared to the 
endomitotic cycles.  
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In this work we have investigated the physiological relevance of several mitotic regulators 
during endomitosis and functional maturation of megakaryocytes. Strikingly, we found that 
modulation of the endomitotic machinery can lead to alternative endocycles besides 
endomitosis that can lead to highly polyploid megakaryocytes. Importantly megakaryocytes 
resulting from alternative polyploidization are functional and able to shed platelets. 
Interestingly we have also identified that crucial mitotic regulators, such as Mastl, while 
dispensable for the endomitotic process, can be essential for non-cell cycle functions during 
megakaryopoiesis such as maturation and platelet shedding through regulation of MAPK 
activity.  
5.1. A new cell cycle-independent function of Mastl 
In 2000, a human autosomal dominant thrombocytopenia syndrome was associated through 
genomic linkage analysis for first time to a genomic region of 17 centimorgans on the short 
arm of human chromosome 10 [10p11-12 (THC2, OMIM number *188000)] (Drachman et 
al., 2000). Affected members presented moderate thrombocytopenia with reduced frequency 
of bone marrow megakaryocytes and no apparent abnormalities of myeloid or erythroid cells. 
This type of inherited thrombocytopenia has no evident association with hematopoietic 
malignancy or progression to aplastic anemia. Furthermore bone marrow cells grown in liquid 
culture with thrombopoietin failed to develop polyploid cells greater than 8C and 
megakaryocytes from an affected individual had markedly delayed nuclear and cytoplasmic 
differentiation. Three years later a novel missense mutation in the human gene FLJ14813 
(currently known as MASTL) located in the THC2 locus segregated perfectly with 
thrombocytopenia in a pedigree of 51 family members (Gandhi et al., 2003). A substitution of 
cytosine for guanidine (G to C) at nucleotide position 565 was present in all 
thrombocytopenic family members, causing a predicted substitution of aspartic acid for 
glutamic acid (E167D) in exon four. A few years later the same group reported that Mastl 
inactivation in zebrafish leads to thrombocytopenia  suggesting that the E167D Mastl 
mutation might be a loss of function mutation (Johnson et al. 2009).  
By generating a new in vivo model of this mutation in knockin mice, we demonstrated 
that Mastl(E166D/E166D) mice develop normally and display only moderate 
thrombocytopenia which seems to be unrelated to any cell cycle function of Mastl during 
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endomitosis. Importantly Mastl E166D displayed similar or even higher kinase activity 
compared to wild-type Mastl in vitro suggesting that this mutation is not a loss of function 
mutation. Accordingly, fibroblasts extracted from Mastl(E166D/E166D) E14.5 embryos 
showed no apparent defects during cell cycling while presented increased phosphorylation of 
Cdks and MAPKs substrates (an established readout for PP2A activity). In agreement with 
Mastl depletion in zebrafish, genetic ablation of Mastl specifically in mouse megakaryocytes 
and platelets leads to thrombocytopenia development to even higher levels and frequency 
compared to Mastl(E166D/E166D) mice. However thrombocytopenic phenotype was 
unrelated to Mastl role in endomitosis since Mastl(/megakaryocytes presented defects 
only in maturation and had similar ploidy compared to Mastl(+/+) or Mastl(E166D/E166D) 
megakaryocytes.  
This apparent discrepancy in the resulting phenotype of megakaryocytes between the 
human thrombocytopenia syndrome and the murine models is likely due to additional gene 
mutations in the human THC2 locus that can control megakaryopoiesis and platelet 
formation. In fact, additional genes in the THC2 locus on human chromosome include 
ACBD5 (Punzo et al. 2010) and ANKRD26 (Pippucci et al. 2011; Noris et al. 2011), both 
described for their relevance in thrombocytopenic phenotype. Importantly a recent report 
showed that megakaryocytes from thrombocytopenic patients with mutations in the ´5 UTR 
region of ANKRD26 gene led to defects in the transcriptional control of this gene resulting in 
abnormal MAPK signaling (Bluteau & Balduini 2014). Since no experimental evidences are 
available about the effect of these mutations on the transcription of adjacent genes we cannot 
exclude the possibility that Mastl expression is similarly altered in presence of these 
mutations. Interestingly our results indicate that MAPK activation pathway is tightly 
controlled by Mastl activity through PP2A inhibition in megakaryocytes and platelets. Since 
Mastl gene in mouse genome is located in chromosome 2 different from the ANKRD26 locus 
we exclude the possibility that mutations in the Mastl gene can affect ANKRD26 transcription. 
 In addition to shedding light on the pathogenic consequences of Mastl mutation in 
human thrombocytopenia, our data identify for the first time a cell cycle-independent function 
of Mastl, a protein only associated to mitosis previously. Since PP2A phosphatases are 
considered as tumor suppressor complexes with high relevance in human cancer, it can be 
proposed that Mastl inhibition can lead to PP2A reactivation in specific tumor types. Thus, 
our data open new possibilities to explore the therapeutic advantages of inhibiting Mastl to 
activate PP2A leading to the subsequent dephosphorylation of critical oncogenic molecules 
such as Erk or Akt (Figure 5.1). 
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Figure 5.1. Mastl controls cell cycle-dependent and independent pathways. In addition to the 
established function of Mastl in the inhibition of PP2A-B55 complexes during mitosis, our data suggest that 
Mastl can also control PP2A activity in other cell cycle-independent pathways modulating the 
phosphorylation or Erk or other signaling pathways known to be dephosphorylated by PP2A such as Akt. 
5.2. Aurora B dispensability in endomitosis 
Although Aurora B role in endomitosis has been a matter of debate, it is well accepted that 
Aurora B is expressed and properly localized throughout the endomitotic phases (Geddis & 
Kaushansky 2004; Lordier et al. 2010). Experiments overexpressing Aurora B in 
megakaryocytes did not alter its polyploidization (Nguyen et al. 2005) but still a loss of 
function model was needed to define if any the role of Aurora B in endomitosis. Interestingly 
chemical inhibition of in vitro megakaryocytic cultures did not alter polyploidization but it 
did induced growth arrest and apoptosis in 2C and 4C megakaryocytic precursors during 
mitosis (Lordier et al. 2010). Accordingly, our work employing a mouse model for genetic 
ablation specifically in megakaryocytes of Aurora B demonstrated that its ablation in vivo 
does not affect megakaryocytic polyploidization or platelet levels suggesting that it is 
dispensable during endomitosis. This lack of phenotype is not surprising since Pf4 promoter 
driving Cre expression is active only in committed megakaryocytes that upregulate Pf4 
leaving untouched hematopoietic progenitors which still undergo mitosis. In addition form 
previous work it is known that Aurora B deficiency allows mitotic entry but provokes 
premature mitotic exit in fibroblasts (Trakala et al., 2013). One could speculate that in 
endomitotic megakaryocytes with suffer an abortive mitosis a premature mitotic exit would 
Discussion 
 
90 
 
not affect further the polyploidization process. These data further support the idea that the 
proper alignment of chromosomes during endomitosis, a process in which Aurora B is 
essential, is dispensable given the lack of segregation in these cells. 
5.3. Megakaryocytes display a functional APC/C during endomitosis 
Since megakaryocytes during endomitosis do not complete late mitotic stages, several studies 
have been focused on the analysis of cyclin B dynamics and its involvement in the 
endomitotic process with controversial results. While in some studies high levels of cyclin B 
has been found (Nagata et al.,1997; Vitrat et al., 1998) some other with megakaryocytic cell 
lines and primary megakaryocytes showed reduced levels of cyclin B (Datta et al., 1996; 
Zhang et al., 1998) suggesting modified APC/C activity during endomitosis. In addition it has 
been postulated that megakaryocytes have an active mitotic checkpoint since megakaryocytes 
present prolonged duration of endomitosis upon nocodazole treatment (Roy et al., 2001). Our 
results have further confirmed the presence of a fully active APC/C in megakaryocytes since 
ablation of the coactivator Cdc20 led to endomitotic arrest in metaphase and a severe absence 
of circulating platelets. In contrast Cdh1, while it has been shown to be essential for 
endoreplicative cycles, it did not affect megakaryocytic polyploidization and platelets 
production during its ablation in megakaryocytes. These results are not surprising since Cdh1 
ablation in fibroblasts did not present serious mitotic defects except for enhanced replicative 
stress (Garcia-Higuera et al. 2008; Eguren et al. 2013), while Cdc20 ablation led to a dramatic 
mitotic arrest (Manchado, Guillamot, et al. 2010). The fact that Cdc20-null megakaryocytes 
arrest as mitotic cells in the bone marrrow demonstrates that endomitosis is the major 
endocycle for megakaryocytic polyploidization not only in vitro but also in vivo.  
The dramatic arrest of Cdc20 null megakaryocytes in metaphase and their incapability 
to progress further in polyploidization allowed us to detect the consequences of the almost 
complete lack of blood platelets. Since TPO is secreted in a constant rate mainly from liver 
and kidneys, its concentration in blood relies almost completely on its binding, internalization 
and clearance form cells that express TPO receptor (c-Mpl). Cells known to express cMpl 
except for megakaryocytes and platelets are hematopoietic stem cells (HSCs) and committed 
progenitors to myeloid lineage. Hence low platelet levels lead to higher free TPO that in turn 
triggers HSCs proliferation and subsequent commitment to megakaryocytic lineage. 
Accordingly in Cdc20(/mice with severe thrombocytopenia we found a dramatic increase 
of hematopoietic progenitors and enhanced commitment to the megakaryocytic lineage that 
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explained the increased numbers of VWF positive cells in bone marrow and spleen. 
Interestingly TPO levels in serum of mutant mice were not significantly increased likely due 
to the high numbers of hematopoietic and megakaryocyte progenitors that bind and internalize 
TPO similarly to other models with altered platelet numbers (Ng et al. 2014). In agreement, 
fetal liver hematopoietic progenitors from Cdc20(/embryos were not upregulated since 
TPO levels are regulated by the pregnant mother’s megakaryocytes and circulating platelets.  
5.4. Alternative endocycles result in polyploid functional 
megakaryocytes 
5.4.1. Endoreplication 
Similarly to cyclin B dynamics, Cdk1 activation during endomitosis remains controvertial 
(Datta et al., 1996; Zhang et al., 1998; Vitrat et al., 1998). Cdk1 is essential for mitotic entry 
and Cdk2 cannot compensate for lack of Cdk1 either in embryos, cultured cells or during 
meiosis (Adhikari et al., 2012; Diril et al., 2012; Santamaría et al., 2007; Satyanarayana et al., 
2008). Inactivation of Cdk1 is known to be sufficient to promote endoreplication in some 
specific cell types but not in others (Itzhaki et al., 1997; LItalien et al., 2006; Niculescu et al., 
1998; Vassilev et al., 2006). We extended these findings in vivo showing that Cdk1 depletion 
in megakaryocytes results in endoreplication and endoreplicative megakaryocytes can reach 
ploidies similar to endomitotic ones with clear delineated genome doublings.  Importantly, we 
demonstrated for the first time that polyploid megakaryocytes from endoreplicative cell cyles 
are functional and can perform platelet shedding. Interestingly these megakaryocytes in 
contrast to the endomitotic megakaryocytes with a single polylobulated nucleus, presented a 
single hypolobulated (mainly mono-lobulated, bi-lobulated and tri-lobulated) nucleus with 
similar nuclear size. We assume that the number of lobules in the endoreplicative 
megakaryocytes depends on the number of endomitotic cell cycles that have undergone these 
cells prior to Cdk1 excision and the switch to the endoreplicative endocycling. Once 
megakaryocytes assume endoreplicative cell cycles the lobule number does not increase 
further since these cells do not enter endomitosis and do not reform its nucleus but augment 
the size of the already existing lobules.  
Concomitant ablation of Cdk1 and Cdc20 in megakaryocytes was sufficient, at least 
partially, to rescue megakaryocyte mitotic arrest and blood platelet levels. While Cdc20 null 
megakaryocytes entered and remained arrested in endomitosis till they died, 
Cdc20(/);Cdk1(/) megakaryocytes escaped mitotic arrest since switch to endoreplicative 
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endocyling  bypassed endomitosis. We can speculate that although Cdc20 and Cdk1 are 
excised simultaneously Cdk1 protein can be more stable and remain longer compared to 
Cdc20 since Cdc20 is controlled by cell cycle-regulated ubiquitin-dependent proteolysis. 
While Cdk1 levels can be permissive for entry into endomitosis lack of Cdc20 leads to 
endomitotic arrest and thus blocks the following endocycle and the switch to endoreplication 
leading only to partial rescue of the Cdc20-null phenotype.  
5.4.2. Re-replication 
While neutralization of Cdt1 is essential to prevent rereplication during S-phase accumulating 
evidences indicate that the block to relicensing during G2 and M phase in mammals is 
critically dependent on Cdk activity. It has been proposed that in hamster cells, 
phosphorylation of Orc1 by Cdk1/Cyclin A prevents its association with chromatin (Li et al., 
2004) Moreover, mouse Cdt1 has DNA-binding activity that is blocked by Cdk, but the 
physiological role of the DNA binding and its regulation have not been established (Sugimoto 
et al., 2004; Yanagi et al., 2002). To test whether Cdk1 directly regulates these pre-RC 
components, it will be essential to eliminate their Cdk phosphorylation sites and ask whether 
they can bind to chromatin in mitosis. The role of Cdk2 in preventing re-replication in 
mammals is controversial. On one hand, lack of an essential role for Cdk2 in regulating DNA 
replication is dramatically underscored by the observation that Cdk2 and Cyclin E knockout 
mice are viable (Ortega et al. 2003; Geng et al. 2003) and  expression of cyclin A enhanced 
re-replication in mammalian tissue culture cells (Vaziri et al. 2003).  On the other hand it has 
been reported that Cdk1 and Cdk2 play redundant roles in preventing re-replication in Hela 
cells (Machida & Dutta 2007). Our data showed that while individual ablation of Cdk1 or 
Cdk2 is not enough to induce re-replication in megakaryocytes, concomitant ablation of these 
two kinases led to substantial levels of re-replication. We need to clarify that endoreplication 
in Cdk1-null megakaryocytes is not considered as re-replication. In endoreplication, even 
though origin licensing occurs in absence of mitosis, it is mediated through a reset in a G1-
like stage with the according APC/C-Cdh1 activation and geminin destruction.  
We speculate that the Cdk2 role in preventing rereplication might be on one hand the 
Cdt1 destruction via SCFSkp2, although there is so far no evidence that elimination of this 
pathway potentiates re-replication. On the other hand, Cdk2 might be important for a robust 
Cdk1 activation for instance mediating the activation of Cdc25B and Cdc25C phosphatases 
that eliminate the Cdk1 inhibitory phosphorylations (Mitra & Enders 2004).  
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Figure 5.2. The quantitative model of Cdk action in fission yeast. Cdk activity pass through two 
thresholds. The first Ts is the necessary activity for beginning of S-phase while the second threshold TM 
defines the necessary activity for mitotic onset. Source: (Coudreuse & Nurse 2010). 
Trying to reconcile all these data it is tempting to speculate that the absolute level of 
total Cdk activity, rather than which specific Cdk and cyclins are present, may determine 
whether S phase and mitosis, or only S phase, and re-replication inhibition occurs. The 
quantitative model of Cdk action first proposed by Stern and Nurse (Stern & Nurse 1996; 
Coudreuse & Nurse 2010) in fission yeast and later substantiated in animal cells (Santamaría 
et al. 2007) shows that Cdk activity pass through two thresholds (Figure 5.2). Below the first 
threshold (TS), in G1, replication origins can be licensed but cannot fire. Thus transition 
above TS marks the beginning of S-phase and continuously growing Cdk activity ensures that 
origins fire only once per S-phase. The second threshold (TM) is passed on the onset of 
mitosis. 
Re-replication leads to DNA damage checkpoint activation and phorphorylation of a 
histone variant H2AX is known to be en early event during this pathway activation. 
Accordingly, megakaryocytes null for Cdk1 and Cdk2 presented strong positive H2AX 
signal. Interestingly polyploid megakaryocytes from rereplicative cell cycles were functional 
and able to form platelets. We think that megakaryocytes can tolerate considerable re-
replication since it is known to express higher amounts of pro-survival proteins such as Bcl-x 
in order to restrain apoptosis and progress safely through proplatelet formation and platelet 
shedding (Josefsson et al. 2011). A summary of the effect of modulating different regulators 
of the cell cyle during megakaryocyte polyploidization is depicted in Figure 5.3. 
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Figure 5.3. Working model for alternative endocycles in megakaryocytes. Megakaryocytes 
polyploidize through endomitotic endocycles. Aurora B and Cdh1 proteins seem to be dispensable during 
this process with Cdc20 shows an essential role for endomitotic exit. Cdk1 ablation in megakaryocytes 
results in endoreplicative cells cyles, while concomitant Cdk1 and Cdk2 ablation lead to re-replication. 
Alternatively endocycling megakaryocytes are functional and can shed platelets. 
5.5. Endomitosis a sophisticated endocycle for platelet formation 
It has been postulated that mekaryocytes undergo polyploidization in order to increase its size 
and upon maturation and fragmention release thousands of platelets. The fact that 
reprogrammed megakaryocytes are functional even in the presence of DNA damage and 
absence of discrete ploidy peaks, suggests that the major, if not the only, function of 
polyploidization is to increase cell size for platelet generation (Thon and Italiano, 2012). 
Since we have showed that alternative endocycles can lead to equally polyploid 
megakaryocytes still it remains unclear why megakaryocytes have chosen along evolution the 
endomitotic cell cycle in comparison for the endoreplicative one. Endoreplication could result 
in the same increased size without the need for the energy consuming mitotic processes. 
However, since endomitosis is the modified cell cycle least variant from the archetypal cell 
cycle, a simple interpretation suggests that megakaryocytes (which do not reach the higher 
ploidy levels observed in other cells such as trophoblast giant cells; >1000C) simply select the 
smaller degeneration of the mitotic cell cycle required for expansion of progenitors to become 
polyploid.  
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Figure 5.4. Proposed model of DMS formation and expansion in megakaryocytes. DMS formation 
initiates at focal areas on the cell surface. During maturation, a distinct pre-DMS structure is formed in the 
perinuclear region, through an invagination process that resembles cleavage furrow formation. Further 
expansion requires vesicular membrane delivery from multiple Golgi complexes that are targeted to the 
developing DMS and possibly via direct lipid transfer through ER- DMS tethering.  Pm (plasma membrane), 
DMS (demarcation membrane system), RER (rough endoplasmic reticulum). Source: (Eckly et al. 2014) 
The slight defects in platelet levels in Cdk1- or Cdk1; Cdk2-null mice and the 
incomplete rescue induced by lack of these kinases in Cdc20-deficient mice may indicate that, 
although endoreplication and re-replication can be functionally used for megakaryocyte 
polyploidization, they are less efficient than endomitosis. One possibility is that endomitotic 
megakaryocytes can shed platelets more efficiently compared to megakaryocytes resulting 
from alternative endocyling. In fact, it has been recently proposed that the multilobulated 
nuclei generated during mitosis may participate in the establishment of the forces required for 
membrane fragmentation during the formation of proplatelets (Eckly et al., 2014). While we 
have not detected significant differences in the percentage of platelet bearing megakaryocytes 
we noticed a slight tendency of endomitotic megakaryocytes to form more complex 
proplatelets. The only difference between an endomitotic megakaryocyte and an 
endoreplicative one is the nuclear shape. The former presents a higly lobulated nucleus while 
the latter usually presents one or two lobules. A recent report has shown that a pre-DMS 
(demarcation membrane system, which forms the plasma membrane of future platelets) is 
formed initially at the cell periphery and is precisely located among the nuclear lobes (Eckly 
et al. 2014). During the whole polyploidization process the DMS remained continuous with 
the cell surface and the number of these connections correlated well with the nuclear 
lobulation (Figure 5.4). It might be that a stable DMS emanating from the center of a 
polylobulated nucleus and connected to several points to the cell surface is critical for the 
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efficient platelet shedding process suggesting that such structure can be more unstable in 
hypolobulated nucleus with less binding regions to the cell surface.  
Megakaryocytes are not the only cell type that has built divergent cell cycles from the 
conventional mitotic ones that better suits their specific structure and function. Another 
example of programmed polyploidization in mammals is heart cardiomyocytes. 
Cardiomyocytes skip cytokinesis leading to binucleated cells (Edgar et al. 2014). To undergo 
cytokinesis, cardiomyocytes should temporarily disassemble their sarcomeres, and this would 
be energy consuming and would lead to a transient loss of contractile function. Thus, 
hypertrophic growth through polyploidization can offer an energy-saving mechanism towards 
increased cardiac mass.  
5.6. Therapeutic modulation of polyploidy in disease 
As we mentioned early in addition to physiological polyploidization events, pathological 
induction or inhibition of polyploidization has been observed in diseased mammals. 
Polyploidization frequently appears in diploid cellular types and tissues, a pathological 
situation observed in cancer and different degenerative diseases (Otto 2007; Davoli & de 
Lange 2011; Pandit et al. 2013). Furthermore, in chronic hepatitis, metabolic diseases, and 
liver cirrhosis, hepatocytes also show increased polyploidy (Guidotti et al. 2003) A similar 
increase in nuclear sizes has been observed in cardiomyocytes, vascular smooth muscle cells, 
endothelial cells, and fibroblasts during hypertension or tissue repair. Overall, the mechanism 
and consequences of polyploidization in pathological settings remain obscure. In degenerative 
diseases, polyploid cells most likely appear in response to stress for example through toxins, 
physical pressure, or inflammation. Poly- ploidization might, therefore, be a stress response to 
preserve cell function and tissue structures, where acute loss would have detrimental effects 
such as in the liver heart or in megakaryocytes progenitors in bone marrow (Pandit et al., 
2013)  
It is also well established that polyploidization can also be a quick route to aneuploidy 
and genome instability (Davoli and de Lange, 2011; Duncan, 2013; Pandit et al., 2013; 
Storchova and Kuffer, 2008; Zasadil et al., 2013). In cancer, mutations in tumor suppressor 
genes and oncogenes have been clearly associated with polyploidization. Inactivation of 
tumor suppressor genes, such retinoblastoma and p53, as well as overexpression of oncogenes 
such as Myc, in mice leads to enhanced polyploidization and tumor formation (Davoli & de 
Lange 2011; Malumbres 2012). The degree of polyploidization is used as a prognostic marker 
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for multiple cancer cell types because high scores have been associated with reduced survival 
(Sinicrope et al., 2006; Syrios et al., 2013). High polyploidy levels might indicate that cancer 
cells within neoplasia increased chromosomal instability due to polyploidization and 
aneuploidization, causing a more malignant behavior. However, whether polyploidization is 
an essential step for generating tumors is largely unknown (Storchova & Kuffer 2008; Davoli 
& de Lange 2011; . It would be interesting to evaluate whether inhibition of polyploidization 
in mouse models of cancer has any consequences for tumor development.  
Recent data has shown that inhibition of Aurora kinases as well as Cdk1 or Cdk2 in 
megakaryocytic leukemia cells leads not only to increase ploidy but also to the expression of 
megakaryocyte differentiation markers (Wen et al. 2012). These results may suggest that 
polyploidization not only accompanies but can actually trigger the differentiation process in 
megakaryocytes. Since Cdk1 is essential for mitosis in all cells tested, it can be expected that 
the differentiation process induced by Cdk1 inhibition (Wen et al., 2012) is actually mediated 
by endoreplication (as shown in our work) rather than endomitosis. The fact that mitotic 
kinases such as Aurora A, Aurora B or Cdk1 are not required for the function of endomitotic 
or endoreplicative cells, while being essential for the normal mitotic cell cycles, opens new 
avenues in the use of inhibitors against these proteins in therapeutic approaches against 
specific human cancers (Krause and Crispino, 2013). 
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Conclusions 
 
 
1. The Mastl E166D mutation, found in thrombocytopenia patients, or complete genetic 
ablation of Mastl does not result in defects in megakaryocyte polyploidization in the 
mouse.  
 
2. Mastl controls circulating platelet levels by modulating Erk dephosphorylation by 
PP2A-B55 complexes, a process required for proper proplatelet formation in mature 
megakaryocytes. 
 
3. Endomitosis does not require Aurora B activity although it is compromised in the 
absence of Plk1 due to partial mitotic arrest. 
 
4. The Anaphase-promoting Complex (APC/C)-Cdc20 is necessary for endomitotic exit. 
However, APC/C is dispensable for platelet production when activated by Cdh1, a 
protein required for endoreplication in other systems 
 
5. The mitotic arrest induced by lack of Cdc20 indicates that endomitosis is the major 
endocycle for megakaryocyte polyploidization in vivo. 
 
6. Cdk1 and Cdk2 prevent re-replication in megakaryocytes. 
 
7. Endomitosis, endoreplication and re-replication can function as alternative endocycles 
for maturation of megakaryocytes. Megakaryocytes resulting from these alternative 
polyploidization processes are functional and able to shed platelets. 
Conclusions 
 
102 
 
  
Conclusions 
103 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7. Conclusiones 
 
 
 
 
 
 
  
Conclusions 
 
104 
 
 
 
 
  
Conclusions 
105 
 
Conclusiones 
 
 
1. La mutación de Mastl (E166D) encontrada inicialmente en pacientes con 
trombocitopenia y la completa ausencia de Mastl en los megakariocitos no conduce a 
defectos durante la poliploidización de estas células. 
 
2. Mastl regula la producción de plaquetas en la sangre mediante el contol de la actividad 
de los complejos PP2A-B55 y la defosforilación de Erk. 
 
3. La actividad de Aurora B no es necesaria durante endomitosis. Sin embargo la 
deficiencia en la quinasa Plk1 provoca una parada temporal en endomitosis y 
trombocitopenia. 
 
4. El complejo promotor de la anafase o ciclosoma (APC/C)-Cdc20 es necesario para la 
salida de endomitosis y su ausencia causa trombocitopenia severa. APC/C-Cdh1, sin 
embargo, es dispensable para la producción de plaquetas mientras que es 
imprescindible para el processo de endoreplicación en otros sistemas. 
 
5. La parada mitótica producida por la falta de Cdc20 indica que la endomitosis es el 
principal endociclo que conduce a la poliploidización de los megakariocítos in vivo. 
 
6. Las quinasas Cdk1 y Cdk2 previenen re-replicación en megakariocitos. 
 
7. La endoreplicación y la re-replicación constituyen endociclos alternativos para la 
poliploidización de megakariocitos. Ambos endociclos son funcionales ya que son 
capaces de producir plaquetas. 
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